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1 Abstract
Signals reaching B cells through the B cell antigen receptor (BCR) expressed on the 
cell-surface can affect both the development, differentiation and activation status of 
B cells. One of the early mediators of signalling through the BCR is the protein 
tyrosine kinase (PTK) Syk. The exact mechanisms how Syk gets recruited to the 
BCR, how it becomes activated and what the downstream targets are in different 
responses still need to be clarified.
Gene targeted homozygous mutant (Syk°) mice stress the importance of Syk in BCR 
signalling. B cell development is severely affected in these mice: very few cells reach 
the immature stage, and even these are prevented from further maturation, pointing to 
at least two steps in B cell differentiation where Syk is implicated.
To further explore the relative contribution of Syk and two other tyrosine kinases,
Lyn and ZAP-70, to the early steps of B cell development, I conducted genetic 
experiments, generating double knockout (Syk°Lyn° and Syk°ZAP-70°) animals.
Analyses of these mice revealed a survival role for Syk and Lyn, a survival and 
differentiation role for Syk and ZAP-70. This latter was surprising, since ZAP-70 has 
not been assumed to function in B cell lineage cells. Results presented here 
demonstrate that ZAP-70 is indeed expressed and functional within B lineage cells, 
and can replace Syk in some, but not all aspects of pre/BCR signalling.
Importantly, pre-BCR signalling leading to differentiation (as defined by changes in 
surface protein expression), proliferation and allelic exclusion cannot proceed without 
the involvement of at least one of the Syk/ZAP-70 family protein kinases.
2 Introduction
2 .1 Early B lymphocyte development In the mouse bone 
marrow
B-lymphocytes are key components of the immune system, as they can take up and 
present antigens to T cells and can differentiate into antibody-secreting plasma cells. 
The aim of B cell development is to generate B-lymphocytes that are capable of 
interacting with the widest possible variety of antigens and that can interact 
efficiently with T lymphocytes without endangering the integrity of the organism. B 
cells are generated in the bone marrow from their precursors through a series of 
developmental stages, passing through multiple checkpoints that can be followed by 
distinct patterns of surface protein expression and also by analysing the generation 
and expression of the B cell receptor (BCR).
The immunoglobulin inserted into the plasma membrane of B cells that serves as 
antigen receptor (BCR) contains heavy and light chains, both of which are composed 
of variable V and constant C portions. The need for a large repertoire of antigen- 
specific B cells carrying unique receptors is served by the mechanism of gene 
rearrangement that during development brings together gene segments coding for 
different parts of the receptor proteins.
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The great diversity stems partly from the possibility of different gene-segment 
combinations and partly from the variability of the junctions, including the non-exact 
positions of crossovers and the addition of extra, non-germline-encoded nucleotides. 
Ontogenically the first step is the recombination of a given (diversity gene of the 
heavy chain locus) segment with one of the four (joining) segments. The signals 
that are needed to start the process are unknown, but since the recombination 
machinery consists of multiple proteins that have to interact with the DNA, attention 
has been focused on locus accessibility (see later in this chapter).
The rearrangement process only becomes entirely B lineage specific at the next step, 
when a (variable) segment is chosen to join a DJ^ pair. If the assembly happens in 
the correct reading frame (1 in 3), a heavy chain protein can be synthesised and tested 
(see below). Light chain generation follows that of the heavy chain, with a similar 
mechanism, but only joining V and J segments. segments in the mouse have been 
grouped into 14 families, altogether consisting of potentially more than 1000 genes, 
followed by 13 Dh genes in three families and the 4 segments. Light chain genes 
are grouped into k  and X systems. The k  locus contains multiple V region families to 
be recombined with one of four segments, whereas the X locus contains only 3 V 
genes with 3 J segments [1].
For a schematic drawing depicting the generation of a jtt heavy chain protein from 
germline encoded gene segments see Figure 1.
Developing B cells in the bone marrow can be subdivided into different fractions 
from early pre-pro-B cells to mature recirculating B cells, as shown schematically 
with the two different nomenclatures in use in Figure 2 [2, 3]. Figure 3 shows the use 
of different antigens as markers of development using the flow cytometer.
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MATURATIONAL STEPS IN B  LYMPHOCYTE DEVELOPMENT
Further subdivision of the pre-pro-B cell population identified the earliest B lineage 
precursors in murine bone marrow as B220^ CD43^ HSA' AA4.1^ CD4^°'  ^BP-1'
CD 19 cells [4] -  see fraction (Fr.) Aj in Table 1. While Fr.Ag cells were shown to 
give rise to macrophages, granulocytes, erythroid colonies, T cells or B cells in vitro, 
Fr. Ai appears to be fully B cell committed [5].
marker A, A, A2 B
AA4.1 + + + +
CD43 + + + +
CD4i°w + + - -
B220 - + + +
HSA - - - +
CD19 - - - +
Mo - +++ +++ -
RAG-1/2 - +/- + +++
IgP - + +4- +++
Ig a - - + +++
À5 - - + +++
Ta b l e  1. S u r f a c e  a n t i g e n  e x p r e s s io n  i n  F r a c t io n s  A  a n d  B. (M o d if ie d  
f r o m : [4 ] )
Other studies have identified a B220^ CD 19' DX5' Ly-6 C subset of bone marrow 
cells as the earliest B precursors, that do not appear to overlap with the above 
mentioned Fr. A cells [6 ].
Transcription from the unrearranged heavy chain locus (denoted as [ i j  is assumed to 
be a marker of locus accessibility, although whether it is only a marker, or a 
prerequisite for recombination is not clear. Detection of [Iq already in Fr. Aj suggests 
locus opening before the rearrangement machinery becomes active.
Among the proteins shown to be indispensable for efficient rearrangement (RAG-1/2, 
DNA-dependent-Protein Kinase, XRCC4, DNA ligase IV, Ku70 and Ku80) most 
widely studied have been the two RAG (recombinase activating genes) proteins. As 
shown in Table 1, RAG-1/RAG-2 activity can be first detected in Fr. A2 and B. 
Accordingly, analysis of the immunoglobulin heavy chain locus shows minimal 
(-4%) Djj to Jh rearrangement in Fr. A2 , that increases to -50%  as cells reach the Fr. 
B stage [5].
Generation of gene targeted mutant mice have helped to elucidate mechanisms and 
molecules needed for distinct developmental steps. Different ‘knockout’ mice show 
impairment of B cell development at different stages, suggesting the involvement of 
the removed gene-product in the process.
RAG-1° and RAG-2° mice show complete lack of immunoglobulin heavy and light 
chain rearrangement, proving that both of these proteins are essential for the 
recombination machinery [7-9]. Dglg, but not Vg-DIg rearrangement was found in 
the IgP° mice, suggesting that IgP - that is already expressed in Fr. A2 and later on 
acts as the signal transducing component of the pre/BCR -  performs essential 
functions even before a pre-BCR or a BCR could assemble [10]. Based on this and 
other experiments revealing IgP expression on the surface of pro-B cell lines, that 
have not undergone heavy chain rearrangement [11], the existence of a pro-BCR was 
proposed. This receptor could be responsible e.g. for initiating/allowing heavy chain 
V-DJ recombination.
The a  chain of the IL-7 receptor was also shown to play a role in allowing Vg to DI^ 
rearrangements, since in IL-7Ra° animals only D-proximal, but not D-distal gene
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families can take part in recombination [12]. No germline transcripts were detected 
from the unrearranged 5’ gene families in these mice, pointing to a defect in locus 
accessibility. The expression level of the BSAP (B cell specific activation protein) 
transcription factor is also decreased in the absence of IL-7Ra. BSAP (encoded by 
the pax-5 gene) has been shown to bind an LCR (locus control region) at the 3' end of 
the IgH locus, and is essential for V-DJg joining early in B lymphopoiesis.
Consistent with this, pro-B cells in BSAP° mice contain Dg-to-Jy rearrangements of 
the Ig HC locus at normal frequency, however Vh-Io-DJh rearrangements are 50-fold 
reduced [13-15].
B cell development in RAG-1° or RAG-2° mice can be rescued by the introduction of 
a pre-rearranged BCR transgene [7], demonstrating that the maturational block was 
indeed due to the lack of immunoglobulin gene rearrangements. A BCR transgene, 
however, does not relieve the developmental block in BSAP° mice, revealing that 
lack of recombination is only partly responsible for the defect [15].
Successful Vh-DJjj rearrangement enables a developing B cell to synthesise a heavy 
chain {p) protein, and transport a small portion of it to the membrane [16]. Pre-BCR 
complex is formed containing in addition to the p  chain the so-called surrogate light 
chain (SLC) components, VpreB and X5 [17-20] and also the signalling chains Iga/p. 
Since the proper triplet codon reading frame must be maintained upon joining the 
different gene segments, productive Vh-DJh rearrangement is expected in about one- 
third of the cases ( ‘in-frame’ joints). In addition, only about 50% of pH  chains are 
capable of associating with SLC to form a pre-BCR, that is assumed to be a 
prerequisite for further developmental progression [21, 22]. Single ex vivo pro-B
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cells proliferate to different extent, suggesting, that the ‘fitness’ of pH-SLC  pairing 
might have a role in determining the expansion of cells carrying distinct heavy chain 
proteins [23].
Phenotypic analyses of gene-targeted mutant mice missing different components of 
the pre-BCR provide us with information about the possible roles of this receptor:
-  RAG-1° and RAG-2° mice: since no recombination can take place, these 
mutations effectively remove the heavy chain component of the pre-BCR. 
These mice show complete developmental arrest at B220^CD43^ pro-B cell 
stage (Fr. C, Figure 2) [7-9].
-  pM T  mice: generated by targeted disruption of the p  chain membrane exon. 
The heavy chain locus undergoes rearrangement, but the protein product 
cannot be inserted into the membrane, the result of which is a developmental 
block at pro-B cell level. Heavy chain allelic exclusion - a process which 
stops recombination on the second allele if the first allele produces a 
productive VDJjj joint, thereby ensuring that each B cell carries only one 
unique receptor - does not occur, resulting in some cells expressing a heavy 
chain protein from each of the two alleles. Light chain rearrangement is 
dramatically decreased, but not absent [24, 25].
-  J^T mice: deleting the whole cluster by gene targeting prevents any heavy 
chain rearrangements in these mice, accordingly, no development is detected 
beyond the B220^CD43^ pro-B cell Fr. C [26, 27].
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X5° mice: in the absence of X5 no proper SLC complex can be formed. B cell 
maturation in these mice is incompletely blocked; the number of pre-B cells in 
the bone marrow is dramatically reduced [28]. The ‘leakiness’ of the mutation 
could be explained by assembly of a jU heavy chain with VpreB in the absence 
of X5, which appears to be possible in a portion of p  heavy chains that are 
normally capable of pairing with SLC [29]. Alternatively, early light chain 
rearrangements can also occur [30], providing the cells with a receptor, that 
cannot signal proliferation but can promote allelic exclusion, since heavy chain 
allelic exclusion is maintained in the absence of X5. In support of this latter 
possibility, combined X5 and Rag- 1  deficiency in the presence of a heavy 
chain only transgene does not allow any progression into the pre-B cell 
compartment [31].
Vpre-Bl° mice: the two Vpre-B genes in the mouse genome (Vpre-B 1 and 
Vpre-B2) both encode proteins that can form a pre-BCR with a p  heavy chain 
and X5. Removal of Vpre-B 1 protein lead to a partial block at the pre-BCR 
checkpoint, resulting in mildly decreased numbers of pre-B (pre-BII in the 
Basel nomenclature) cells, suggesting that Vpre-B2 can efficiently, though not 
completely substitute for Vpre-B 1 [32].
Vpre-B 1° Vpre-B2° mice: upon removal of both VpreB gene products, no 
surface expression of any of the SLC components can be detected. Pre-B cells 
cannot expand resulting in severely reduced (-40-fold) pre-B cell numbers in 
the bone marrow showing the importance of a proper pre-BCR in inducing 
proliferative expansion. Surprisingly, allelic exclusion at the heavy chain 
locus is maintained. This finding could be explained by the assembly of yet to
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be identified proteins with the p  heavy chain into an alternative pre-BCR, or 
light chain rearrangements happening earlier than normal, possibly helped by 
lack of proliferation [33].
Djj segments can be read in all three reading frames (RF), however, the frequency of 
the three RFs found in mature B cells are not equal. About 70% of mature B cells 
carry D regions using R Fl, 30% uses RF3, and only 3% use RF2. The dominance of 
R Fl over RF3 is mainly due to STOP codons in RF3 in 8  of 12 regions. RF2 is 
unique, in that it allows synthesis of the so-called Dp protein without the addition of 
any regions. This Dp  protein can form a complex with VpreB and X5 and 
assemble into a pre-BCR-like receptor with Ig a  and Igp. RF2 underrepresentation, 
which is already evident in pre-B cells, requires the membrane form of the protein, 
and also needs X5. Signalling through this receptor complex results in allelic 
exclusion, that is no further rearrangements can occur at the heavy chain locus [34- 
36]. Underrepresentation of RF2 suggests that this receptor cannot induce all the 
signalling events that a proper pre-BCR is capable of [37].
Pre-BCR signalling has been shown to cause down-regulation of Rag 1/2 activity and 
the synthesis of SLC components -VpreB and X5 -  is also turned off, which allows 
allelic exclusion to occur and also leads to the cessation of the pre-BCR signal [38].
At the next stage of development the SLC will be exchanged for conventional light 
chains (see below). Whether the pre-BCR induces light chain rearrangement or not is 
a matter of debate. Light chain rearrangements have been shown to occur even in the 
absence of any heavy chain recombination [30, 39]. On the other hand, induced pre- 
BCR expression in previously pre-BCR~ cells lead to germline Kq transcription and 
rearrangement [40, 41]. These conflicting data can be reconciled by suggesting that
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pre-BCR is not strictly required for light chain rearrangement, but the 
frequency/efficiency of light chain recombination is increased by signals emanating 
from the pre-BCR.
As mentioned above, IL-7Ra is critical for complete Vh-DJh rearrangement.. At a 
later stage, at the pro-B->pre-B transition, pre-BCR assembly and expression was 
needed for increased IL-7 responsiveness, suggesting that the interplay between the 
pre-BCR and IL-7 allows proliferation at this maturational step [42-44].
In summary, the role of the pre-BCR is to
-  promote differentiation of pro-B cells into pre-B cells
-  selectively amplify pre-B cells that have a productively rearranged p  heavy 
chain gene coding for a protein capable of associating with the SLC
-  ensure allelic exclusion at the heavy chain locus
-  arrest DjU producing cells
-  promote light chain rearrangement
-  downregulate SLC expression
-  increase IL-7 responsiveness.
The next stage of B cell development leads to the maturation of pre-B cells into IgM 
expressing immature B cells. The hallmark of this step is the replacement of the pre- 
BCR with a conventional BCR that necessitates the complex formation between the 
tested p  heavy chain and a newly synthesised light chain. After the proliferative 
phase -  induced by pre-BCR signalling -  pre-B cells have to enter a resting phase, so 
that they can re-induce RAG protein expression that is down-regulated in dividing 
cells [45].
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As mentioned above, light chain genes are organised into k  and X loci. Analyses of 
light chain rearrangements [29,46-49] have shown that:
-  light chain rearrangements are completely absent in Fr. C’ (large pre-BII in the 
Basel nomenclature) cells, and become prominent in the Fr. D (small pre-BII) 
population;
-  most B cells have their X locus in germline configuration, whereas most X 
expressing cells have non-productive rearrangements on both of their k  alleles, 
the majority of these using the most 3’ Jk segments, suggesting that K 
rearrangements precede that of the X locus;
-  K and X LC loci can rearrange independently of each other, since prior 
recombination of a k  allele is not prerequisite for X rearrangement as 
demonstrated using mutant mice incapable of rearranging k
-  rearrangements at the k  locus are induced 5-10-fold more frequently than at 
the X locus, they also start earlier, which leads to the - 1 0 : 1  ratio of k:X 
rearrangements that is established as soon as light chain rearrangements start
-  cells can attempt multiple rearrangements on the same K allele -  probably to 
replace the original rearrangement that was either out-of-frame, produced a 
light chain protein that was incapable of pairing with the heavy chain 
expressed in the cell, or formed an autoreactive BCR with the p chain (see 
‘receptor editing’ below).
A second major checkpoint in B cell development (the first being the pre-BCR step) 
is the testing of the newly formed BCR. Since B cells carrying a BCR specific for
16
an autoantigen could be deleterious for the organism, the process of negative 
selection is needed to ensure that only self-innocuous B cells leave the bone 
marrow.
A number of different mechanisms of tolerance/negative selection have been 
described for B lymphocytes acting at different stages of maturation:
-  receptor editing: preserves the cell, but eliminates the original receptor that 
proved to be autoreactive. This can be achieved by exchanging the heavy or 
light chain of the receptor by secondary rearrangements [50-54]. The original 
K light chain rearrangement leaves upstream Vk and downstream Jk segments 
intact and available for subsequent recombination. Heavy chain replacement, 
however, is mechanistically more complicated, since VyDJy rearrangement 
eliminates the sequences between the segments used (see Figure 1); the cryptic 
recombination signal sequences (RSS) that can be used for this type of 
secondary heavy chain recombination are embedded at the 3' end of most 
genes [55-57].
This method of negative selection appears to be ontogenically the first 
possibility : emerging B lymphocytes expressing low levels of IgM respond to 
their cognate ligand by increased RAG expression, making continued 
immunoglobulin rearrangements possible [58];
-  clonal deletion eliminates autoreactive B cells from the repertoire by apoptosis 
[59-62]. The likely target cell population for deletion is the so-called 
transitional cells. These cells are in transition from the immature (HSA^"^% 
B220'^““) to the mature (HSA'^"”, B220^"^^) stage. They also express high levels 
of IgM, Fas antigen, but no anti-apoptotic Bcl-2, which makes them rather
17
sensitive to this form of negative selection [58, 63]. Cells at this transitional 
stage are believed to be leaving the bone marrow for the periphery, which 
might also contribute to their increased sensitivity to deletion rather than 
receptor editing : cellular elements of the bone marrow were shown to be 
protective against apoptosis [64];
anergy preserves the cells, but they are rendered inactive (e.g. do not secrete 
antibody) after they meet their cognate ligand. Using the HEL (hen egg 
lysozyme) system, where anti-HEL BCR transgenic cells meet their cognate 
ligand in soluble (sHEL) form, IgM expression levels are reduced on anergic B 
cells (while IgD expression is maintained) as a sign of previous antigen 
encounter. The life span of these cells is much shorter [65], which -  analysing 
normal, polyclonal populations -  may make anergy almost indistinguishable 
from deletion [66-69]. Whether cells get deleted or anergized probably 
depends on the quality of receptor-ligand interaction, including avidity, 
receptor cross-linking [61] or the possibility of repeated antigen encounter 
[70];
follicular exclusion: anergic cells -  when competing within a normal 
repertoire of B cells - do not seem to be able to enter the long-lived follicular 
B cell population of the spleen. This exclusion leads to shorter life span (1-3 
days) which is inversely proportional to the degree of self-reactivity. Being 
confined to the outer T cell zone, these anergic B cells are destined to die, 
unless a robust signal (e.g. a strongly cross-reactive foreign antigen) rescues 
them from death. Since these anergic cell require a more powerful signal for 
their activation, and because without this signal, they are short-lived, the risk 
of autoimmunity induction is probably smaller, than the advantage that can be
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gained by the extension of the repertoire by granting them a ‘second chance’ 
[67, 71, 72];
-  another interpretation of the above findings that led to the concepts of anergy 
and follicular exclusion is that these two phenomena are detectable in 
transgenic systems only, where the competition between cells is artificially 
kept at minimum. Under more physiological circumstances, in a competitive 
environment, no or very few anergic cells are seen. In the HEL system the T 
cells were shown to be tolerant, therefore there is no T cell help available. The 
B cells see their cognate antigen, move into the T zone and eventually die.
This process is essentially peripheral tolerance effected by lack of T cell help.
-  peripheral tolerance: in addition to central tolerance affecting developing B 
lymphocytes in the bone marrow, clonal deletion or anergy can affect mature 
B cells in the peripheral organs, as well, which is essential for autoantigens 
only expressed outside of the bone marrow [73-75].
Some autoreactive cells can also escape deletion and survive in the peritoneal cavity 
as B-1 (see below) B cells, expanding in the absence of antigen, and contributing to 
autoimmunity [76, 77].
B1 cells [78] are a special subset of B cells that in mouse is mainly found in the 
peritoneal cavity. Phenotypically these cells are B220^°'  ^IgM^ IgD CD23 Mac-U, 
expressing (Bla) or not (Bib) CD5. B1 cells are self-renewing, they secrete IgM, 
IgG3 and IgA and are thought to be responsible for natural immunity.
There are interesting similarities between anergic B cells and cells of the B l(a) 
lineage: both express CD5, have received stimulation by antigen, show suboptimal 
response to B cell receptor crosslinking in vitro, have undergone extensive receptor
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editing and both are excluded from germinal centres [79]. Whether there is more 
connection between anergic and B1 cell populations than mere phenotypic 
resemblance is currently a focus of interest.
In addition to negative selection, evidence is accumulating that a ‘positive selection’ 
mechanism also operates. The aim of this process would be to ensure that only cells 
equipped with a functional, well-fitting heavy-light chain pair could enter the long- 
lived, mature B cell pool.
First indication for the existence of positive selection in B cells came from 
comparison of HC and LC gene usage in the bone marrow and in the periphery [80- 
82]. Results from these studies show that the peripheral repertoire is more restricted 
than that of the bone marrow, suggesting that only cells with ‘selected’ receptors are 
allowed to complete maturation. Also, since mature B cells need continuous 
‘tickling’ of their BCR for survival [83], it seems reasonable to assume that BCRs 
need to be selected before the cells reach full maturity.
Direct evidence for positive selection comes from a study of B 1 cells showing 
naturally generated autoreactive cells accumulating only in the presence of 
autoantigen [84]. Experiments on another special B cell subset, the marginal zone B 
cells also suggest the existence of positive selection in the B lineage [85].
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2.2 Signal transduction in B lymphocytes
The main aim of B cell development is to provide the organism with B-lymphocytes 
carrying unique receptors that enables them to bind and react to antigens. As 
mentioned above, during maturation the components of the B cell receptor are tested, 
which inevitably involves signal transduction through the different versions of the 
BCR, though whether or not an external ligand is also involved in the ‘tests’ is still a 
matter of debate.
Most of the studies analysing signal transduction through the BCR have used mature 
B lymphocytes, and whether the same mechanisms operate similarly in B cells at 
earlier stages of development has for most processes not been confirmed yet.
Signal transduction through the B cell receptor on mature B cells is initiated by ligand 
binding to the receptor complex, that is composed of a membrane-bound 
immunoglobulin noncovalently bound to an Iga/p  complex in 1 : 1  stoichiometry. 
Monomers of the BCR appear to form oligomeric complexes on the cell surface, 
which is probably crucial for efficient signal propagation [8 6 ].
Among the earliest events after receptor crosslinking is tyrosine phosphorylation of a 
group of cellular proteins (reviewed in [87-91]). Since the BCR does not have 
intrinsic tyrosine kinase activity, it has to recruit cytoplasmic protein tyrosine kinases 
(PTK) using its signalling components, Ig a  and IgP. The cytoplasmic tail of both of 
these coreceptors harbours an IT AM (Immunoreceptor Tyrosin-based Activation 
Motif) sequence: (D/E)x7(D/E)xxYxxL/Ix6-8YxxL/I [92]. The tyrosines in these
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IT AMs are rapidly phosphorylated upon receptor ligation probably by Src-family 
tyrosine kinases (Lyn, Fyn, Blk and/or Lck), since a small amount of these kinases is 
associated with the BCR before stimulation [93], and they are among the earliest 
kinases to be activated upon BCR stimulation [94]. If both IT AM tyrosines are 
phosphorylated (about 20% of the IT AMs), they become binding sites for the tandem 
SH2 domains of the Syk protein kinase (see Syk structure, below) of the Syk/Zap-70 
family of tyrosine kinases. Activation of Syk ensues, either by auto-phosphorylation, 
cross-phosphorylation by neighbouring Syk molecules, and/or by Src-family kinases 
(See Figure 4, No.L).
Active Syk is required for the recruitment/activation of the adapter protein BLNK (B 
cell LiNKer protein), that couples Syk to multiple downstream signalling cascades 
(Figure 4, No.2) [95-98].
One of the targets recruited by BLNK is PLCy (phospholipase-Cy) that also binds to 
and becomes phosphorylated by Btk (Figure 5 )and potentially Syk (Figure 4, No.3.). 
PLCy cleaves the membrane lipid component PIP2 (phosphatidylinositol-4,5- 
bisphosphate) to IP3 (inositol-1,4,5-trisphosphate) and DAG (diacylglycerol). DAG 
leads to PKC (protein kinase C) activation, whereas IP3 is crucial in the regulation of 
intracellular C a^ concentration (see below and Figure 5). Elevated Ca"^ level leads 
to the dephosphorylation and nuclear translocation of NF-AT (nuclear factor of 
activated T cells) via the calcium-dependent phosphatase, calcineurin; N F -kB 
proteins c-Rel and RelA also move to the nucleus as a result of increased Ca^^ 
concentration (Figure 4, No.4), where they regulate gene expression.
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Another pathway starting from Syk and BLNK involves the tyrosine phosphorylation 
and activation of Vav, that acts as a GEF (guanine nucleotide exchange factor) for the 
Rho family of GTPases (Rac-1, RhoA and Cdc42). Their downstream targets include 
the ERK (extracellular signal regulated kinase), INK (c-Jun N-terminal kinase) and 
p38 kinases and the cytoskeleton (Figure 4, No.5) [96, 99],
-
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STIMULATION.
See text for description. For additional molecules and pathways see also Figure 5.
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Cbl (cellular homologue of the transforming gene of the Cas-NSl murine retrovirus) 
has also been shown to bind to and be phosphorylated by Syk [100,101]. More 
recently Cbl has been shown to be an E3 ubiquitin ligase [102], and as such appears 
to regulate Syk ubiquitination and degradation [103]. In DT40 chicken B lymphoma 
cells Cbl was able to interact with BLNK, obstruct BLNK-PLCy2 interactions, 
thereby preventing PLCy2 activation [104] (Figure 4, No.9.). Both of these 
mechanisms are probably part of a negative feedback loop leading to termination of B 
cell activation.
Following BCR crosslinking, BLNK can also associate with Grb2, translocate to the 
membrane and activate the Ras pathway via Grb2/Sos (Son of Sevenless; GEF for 
Ras) complex [95] (Figure 4, No.6 ). Syk can also activate the Ras pathway 
independently of BLNK: Syk interacts with and phosphorylates She which also 
results in membrane localisation of the Grb2/Sos complex and in Ras activation 
(Figure 4, No.7) [95, 99].
Ras activates its downstream effector, the serine-threonine kinase Raf-1, which in 
turn activates the MAPK kinase MEK, that will activate the MAP kinase ERK 
leading among others to the activation of p90Rsk (mitogen-induced S6  
serine/threonine kinase) and to the induction of Egr-1 early response gene (Figure 4, 
No.8 ) [105, 106, 107 504].
As mentioned above, Syk recruits and phosphorylates PLCy2 via BLNK (Figure 5, 
No.L), leading to the production of IP3 (Figure 5, No.2.). IP3 allows Ca"^  ^release 
from IP3 receptor-gated intracellular stores (Figure 5, No.3.). This can be detected as 
the initial rapid peak in Ca"^ flux measurements. Btk (Bruton’s tyrosine kinase), a 
member of Btk/Tec family of protein tyrosine kinases, is also important in activating
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PLCy2 (Figure 5, No.4), thereby enhancing peak IP3 levels leading to a profound 
depletion of intracellular calcium stores. This store depletion results in the opening of 
plasma membrane Ca^^-channels via store-operated calcium entry (SOC) mechanism 
(No.5.), making Btk responsible for the sustained increase in intracellular Ca^^- 
concentration following BCR activation [108-110].
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F i g u r e  5. A d d i t i o n a l  m o l e c u l e s  i n v o l v e d  i n  B C R - m e d ia t e d  s i g n a l l i n g  t h a t
ARE ESPECIALLY IMPORTANT IN REGULATING INTRACELLULAR CA^^ CONCENTRATION.
Btk activation requires phosphorylation by Lyn, binding to tyrosine phosphorylated 
BLNK and also membrane localisation, which is achieved by binding of PIP3
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(phosphatidylinositol-3,4,5-trisphosphate) to the PH (pleckstrin homology) domain 
of Btk (Figure 5, No.6 ) [111]. PIP3 also binds to the PH domain of PLCy, thereby 
contributing to the membrane localisation of this lipase [1 1 2 ].
PIP3 is a product of PI3K (phosphatidyl-inositol-3-kinase), which in turn is subject to 
multiple potential regulatory pathways: (a) PI3K can associate with CD 19, but only 
after BCR crosslinking that leads to lyn activation, which in turn can phosphorylate 
multiple tyrosine residues in the cytoplasmic tail of CD19 [113] (Figure 5, No.7); (b) 
Vav-3 can also activate PI3K, possibly via Rac-1 stimulation[114]; (c) Syk can also 
contribute to PI3K activation [115].
PIP3 is substrate for SHIP (src homology 2 domain-containing inositol 5'- 
phosphatase), that converts PIP3 into phosphatidyl-inositol-3,4-bisphosphate (PI-3,4- 
P2), thereby reducing PIP3 levels. Removal of PIP3 leads to Btk inactivation and loss 
of the sustained Ca"^ increase upon B cell stimulation. SHIP is recruited to the 
signalling complex by FcyRIIb, the low affinity receptor for IgG that acts as a 
negative modulator of BCR signalling (N0 .8 .) [116-118]. FcyRIIb, as several other 
negative regulatory receptors, carries an ITIM (immunoreceptor tyrosine-based 
inhibitory motif) sequence - (I/V)x(p)YXXL - in its cytoplasmic tail, that serves as a 
binding site for SHIP.
Another negative modulator of Ca"^  ^signalling is SHP-1 (Src-homology domain 2 
containing tyrosine phosphatase-1). Upon BCR ligation activated Lyn 
phosphorylates and recruits CD22 to the receptor complex, whose phosphorylated 
ITIM in turn binds SHP-1. SHP-1 seems to influence multiple early and late events 
in B cell activation: it inhibits Syk, Lyn and PLCy2 activation, leading to decreased 
Ca'^ release from intracellular stores and also blocks ERK activation [119, 120]. 
Moreover, since SHP-1 is weakly associated with the resting BCR, and has been
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shown to dephosphorylate Iga/p in vitro, SHP-1 might be responsible for keeping the 
BCR complex in an unphosphorylated, quiescent state [121].
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2.3 Signal transduction in early B lymphocyte development
The earliest B cell specific receptor appears to be the pro-BCR, which was found on 
the surface of pro-B cells before any heavy or light chain rearrangement occurs [11]. 
In the absence of any clonotypic component, this receptor contains CD79a/Iga and 
CD79b/Igp chains in complex with calnexin and other as yet unidentified proteins 
[11]. In RAG° bone marrow cells this receptor has been shown to be capable of 
signalling molecules become tyrosine phosphorylated (Syk, Vav, p i 10 PI3K, ERKl; 
Iga) [122]. Also, as mentioned in the previous chapter, Igp° mice show D-Jg, but not 
V-DJh recombination, suggesting a role for an IgP-containing receptor prior to any 
jLtHC expression [10]. A similar complex has been also found on the surface of pro-T 
cells (CIC: clonotype-independent complex) that is assumed to influence T cell 
maturation before the start of TCRp expression [123, 124]. Identification and 
removal of the other -  as yet unknown -  components of the putative pro-BCR should 
help elucidating the role and importance of this receptor in early B cell development. 
In vivo crosslinking of IgP on the surface of RAG° pro-B cells was shown to induce 
differentiation as measured by loss of CD43, X5 and c-kit expression and upregulation 
of CD25, BP-1 and CD2 [122]. This response is thought to mimic a pre-BCR signal 
in the absence of [X heavy chains in these recombinase-deficient pro-B cells.
The signal transduction machinery involved in the pre-BCR checkpoint has also been 
described with the help of gene targeted mutant mice:
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Ig(3° mice: as mentioned above, no Vy-DJg rearrangement takes place in these 
mice, therefore the role of IgP as a component of the pre-BCR cannot be 
assessed [1 0 ].
Igg"^ ^^ ^^  mice: while no complete knockouts of the Ig a  gene have been 
reported, truncation of the intracellular portion of this pre-BCR component 
leads to the accumulation of 70% more than normal pro-B cells, suggesting a 
partial block at the pre-BCR step [125].
I g g ^ ^  / Igp^^ '^' mice: combination of Ig a  cytoplasmic tail tyrosine to 
phenylalanine mutations with truncation of the Igp protein cytoplasmic tail 
leads to a eomplete arrest of B cell development at pro-B cell stage, 
demonstrating the importance of Iga/p  as pre-BCR signal transducing 
components [126];
Syk° mice: in the absence of Syk protein tyrosine kinase B cell development 
is blocked incompletely at the pro-B -> pre-B, and completely at the immature 
mature transition (see below in detail) [127,128];
BLNK° mice: removal of BLNK adapter protein leads to incomplete block at 
the pre-BCR step resulting in increased numbers of pro-B cells, while reduced 
numbers in subsequent maturational stages. IgM expressing cells do develop 
and with time accumulate in the periphery, but are less responsive to BCR 
stimulation than wild type B cells [129,130].
xid fX-linked immunodeficiency] mice: a point mutation in the PH domain 
(R28C) of the btk gene causes XLA (X-linked agammaglobulinemia) in 
humans and a milder immunodeficiency in mice. Xid mice show somewhat 
impaired pro-B to pre-B transition [131] and defective X light chain
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rearrangement [132]. Anti-Igp treatment of RAG-2° pro-B cells cannot induce 
differentiation into pre-B cells in the absence of Btk, also suggesting a role for 
Btk in pro-BCR and/or pre-BCR signalling [133].
-  BLNK° xid mice: combined mutations resulting in the absence of both BLNK 
and functional Btk leads to a much more severe phenotype than the single 
mutations: B cell development is blocked, albeit incompletely at the 
B220+CD43+CD25+pre-BCR+ Fr. C’ (large pre-BII) stage [134].
-  CD 19 transgenic mice: while removing CD 19 does not lead to any obvious 
perturbation of B cell development in the bone marrow, overexpression of 
CD 19 in the form of a transgene causes early B cell maturation defect, with 
normal B220^ IgM' pro- and pre-B cell numbers, but significant reduction in 
the number of B220^ IgM^ bone marrow cells [135].
The phenotype of the above mutant mice suggests that at least some of the key 
molecules are shared between pre-BCR and BCR signal transduction. There are, 
however, several knockout mouse models showing significant defects at the immature 
mature B cell transition, that show no, or only mildly impaired B cell maturation at 
the early steps in the bone marrow, e.g. lyn°[136, 137], CD45° [138], xid [139, 140], 
PKCP° [141], p85a(PI3K)° [142], vav-l°vav-2° [143], PLCy-2° [144], or lyn°xid 
[145] mice.
The lack of earlier B cell developmental impairment in these mutant mice might 
suggest different ‘wiring’ from the pre-BCR and from the BCR, or might reveal 
higher level of redundancy at the early steps.
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2.4 Syk/ZAP family of protein tyrosine kinases
Protein tyrosine kinase Syk has been shown to be important in a variety of cell types 
of the haemopoietic system: B and T lymphocytes, mast cells, NK cells, 
macrophages and platelets [146,147]. The protein sequence of Syk (and Zap-70) 
predicts a structure of two SH2 domains and a kinase domain (Figure 6 ).
Both SH2 domains have been shown to be necessary for Syk binding to tyrosine- 
phosphorylated Iga and Igp, and this binding is essential for phosphorylation at Y519 
and Y520 after BCR ligation [148]. Tyrosines 518 and 519 were found to be the 
major autophosphorylation sites on Syk, and in vivo they are indispensable for signal 
propagation [149]. Since Syk with mutated tyrosines at 518 and 519 is still almost 
fully kinase-active, these phosphotyrosines are probably more important in allowing 
protein-protein interactions (e.g. Src-family kinase binding to Syk) than directly 
influencing Syk enzymatic activity [150].
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The tandem SH2 domains are shown as light cylinders, the kinase domain as dark 
cylinder, the tube depicts the linker region connecting them. The dark section refers 
to the linker insert (Syk only) that differentiates Syk from SykB. Also shown are the 
tyrosines mapped in Syk as potentially important phosphorylation sites. Some of 
these - but not all - have been shown to map to homologous regions in ZAP-70.
Several other tyrosines were shown to be important in interacting with known 
downstream effectors:
-  Y342 and to a lesser degree Y346 within the linker region of Syk are required 
for interacting with Vav [99];
-  Y316 is a putative Cbl binding site [151];
-  tyrosines in the linker region (e.g. Y341) are necessary for interaction with the 
C-terminal SH2 domain of PLCy [152].
In addition, phosphorylated Y130 causes conformational changes in the inter-SH2 
domain, altering both the SH2-SH2 interface interactions and the interactions between 
the inter-SH2 region and the kinase active site. It has been proposed that 
phosphorylation of Y130 negatively influences the binding of Syk to the antigen
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receptor and at the same time allows increased access of the catalytic site to protein 
substrates [153].
The linker region is highly susceptible to proteolysis, and is thus likely to be exposed 
in vivo, suggesting participation in protein-protein interactions; it probably functions 
as a hinge - regulating intramolecular interactions between the N- and C-terminal 
portions of Syk [154]. The 23 amino-acid linker-insert found in Syk, but not in the 
alternatively splice isoform SykB, appears to facilitate IT AM binding [155].
K396 in the catalytic, kinase domain is located within the ATP-binding site, whereas 
the above mentioned Y518/519 lie in the conserved activation loop [146].
Figure 6  shows very similar domain structures for Syk and ZAP-70, the only two 
known members of the Syk/ZAP family of protein tyrosine kinases. There are, 
however, important differences between the two kinases:
-  expression pattern: Syk is known to be expressed in almost all haemopoietic 
cell lineage, in vascular endothelium and mammary epithelium, whereas ZAP- 
70 appears to be restricted to T and NK lineage cells [156];
-  the catalytic activity of Syk is ~ 100-fold greater than that of ZAP-70, which 
seems to be an intrinsic characteristics of the respective catalytic domains 
[157]
-  comparison of the crystal structures suggests that the two SH2 domains in Syk 
are more flexible and more independent from each other, than is the case for 
ZAP-70, offering an explanation why Syk might be able to interact with a
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wider variety of proteins, which might also explain its ubiquitous expression 
pattern [158];
Syk can be activated in the absence of Src family tyrosine kinases (SFK), 
whereas ZAP-70 depends on SFKs; a possible explanation for this difference 
may come from tyrosines 519,520 in the activating loop, that are substrates for 
autophosphorylation in Syk, but not in ZAP -70  [146];
Other receptors that can bind Syk upon ITAM phosphorylation
A number of receptors, known as immunoreceptors, found on the surface of 
haemopoietic cells show strong structural similarities: they all have separate subunits 
for antigen recognition and signal transduction (see Figure 7.). They include the 
TCR, FceRI, FcyRI and FcyRIII. Similarly to the B cell signalling described above, 
ligation of these receptors induces ITAM phosphorylation and Syk recruitment.
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The majority of T cells recognise antigen via the TCR (T cell receptor) aP  dimer 
expressed on their surface in complex with the signalling CD3 subunits y, Ô, 8  and Ç. 
In a smaller population of T cells TCR y and 8  substitute for the aP  dimer (not 
shown). Similarly, B cells use the membrane-bound IgM tetramer (2 heavy + 2 light 
chains) for antigen recognition, whereas the signalling function of the B cell receptor 
(BCR) comes from the Iga/Igp heterodimer (CD79a/b). The other three receptors 
shown bind the Fc portion of IgE (FceRI) or IgG (FcyRI, FcyRIII) antibodies and also 
consist of recognition and signalling chains. FceRI is found on mast cells and 
basophils, while the FcyRs are expressed on macrophages, neutrophils and NK cells. 
FcyRIIA (not shown) combines the Ig-like subdomain and the ITAM in one chain. 
Some FcyRIIIs contain Ç chains instead of FcRy; conversely, some TCR complexes 
use FcRy instead of Ç
The balls in the recognition subunits symbolise the Ig-like subdomains, while the 
ITAM (Immunoreceptor Tyrosine-based Activation Motif) sequences are shown as 
cylinders.
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2.5 Gene targeted mutant Syk° mice
Generation and analysis of gene-targeted mutant mice carrying no functional syk 
alleles lead to further dissection of the role Syk plays in B cell development and 
function. [127, 128]. Syk° mice die around birth for as yet unknown reasons, though 
extensive petechial haemorrhaging throughout the fetal body that is visible around 
day 16 of gestation (Figure 8 ), points to a defect in vascular endothelium, platelet 
function or wound healing.
F i g u r e s . H a e m o r r h a g e s  i n S y k ° e m b r y o s
16.5 day old embryos are shown of the indicated genotypes. The Syk° embryo shows 
characteristic petechiae and haemorrhaging throughout the body, accompanied by 
oedema.
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B cell development is severely affected in these mice: irradiated mice reconstituted 
with Syk-deficient fetal liver showed a partial block in B-cell development at the pro- 
B to pre-B cell transition, consistent with a key role for Syk in pre-B-cell receptor 
signalling. This block is not complete, as immature cells are generated albeit in 
reduced numbers. These cells, however, cannot complete their maturation and 
become recirculating mature IgMTgD"^ cells, suggesting a second developmental 
block in the absence of Syk, a complete block at the positive selection step (Figure 9) 
[128,159] .
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F i g u r e  9 . B  c e l l  d e v e l o p m e n t  b l o c k  i n  t h e  a b s e n c e  o f  S y k
Donor-derived bone marrow cells from chimaeric mice are shown. As donors day
16.5 fetal liver cells from embryos of the indicated genotype were used.
A few immature syk° B cells can travel from the bone marrow to the spleen, but they 
are found lined up at the edge of the T cell zone, and they do not enter the follicles. A 
possible explanation for this could be impaired chemokine-signalling, based on the 
similar phenotype seen in the BLR-1° mice [159,160].
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Introducing a HEL (hen egg lysozyme) -  specific BCR into Syk° animals together 
with soluble HEL as cognate antigen at levels that in Syk"^  animals do not affect B cell 
maturation markers, leads to IgM downregulation, potentially suggesting a negative 
role for Syk in this model of B cell negative selection [161].
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3 Aims of the work In this thesis
B lymphocyte development progresses through multiple stages, that are defined by 
distinct gene expression patterns. One of the major checkpoints a developing B cell 
has to pass through is the pre-BCR signalling step, allowing differentiation of pro-B 
cells into pre-B cells. The signalling molecules taking part in this process and the 
mechanism of their interactions are the focus of this work. In particular I have been 
interested in the role of Syk/ZAP-70 family protein tyrosine kinases. Removal of Syk 
in gene targeted mutant mice has a major effect on B cell development, resulting in a 
severe, but incomplete block at the pre-BCR step. This partial block suggests that 
other pathways can also operate that can mediate pro-B pre-B transition or that 
other molecules can replace Syk in this process. Using combination mutant (double 
knockout) and transgenic animals I attempted to define alternative routes that can lead 
from the pre-BCR to changes in gene expression.
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4 Results
4.1 Radiation chimaeras generated from frozen fetal livers
Mice carrying no functional alleles of the syk gene (Syk° mice) die perinatally [127], 
therefore all analysis of B cell development in mice carrying this mutation must be 
carried out in radiation chimaeras. We have been using fetal liver cells to reconstitute 
the radiosensitive haemopoietic system of lethally irradiated ( 1 0 0 0  rads) recipient 
mice. In these experiments donor-derived cells must be identified using an 
appropriate marker, since the depletion of host cells is never entirely complete. 
Furthermore, if the donor fetal liver cells also carry transgene(s), we have to make 
sure that the transgene is only present on one of the alleles, so as not to disrupt 
potentially important sequences on both alleles at the unknown integration site. 
Finally, we wanted to inject fetal liver cells of multiple different genetic compositions 
on the same day into the same cohort of irradiated recipients. To generate chimaeric 
mice from fetal livers of the same embryonic age and to make sure of having a 
complete set of all required genotypes, we have to know the genetic makeup of the 
livers prior to reconstitution. All these requirements make the use of freshly 
harvested fetal livers as donors difficult, if not impossible.
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As an alternative, we decided to try to generate a ‘library’ of frozen (-70°C) fetal 
livers, that would enable us to collect livers of all the desired genotypes over several 
weeks, which can then be used for reconstitution at the same time at a later timepoint.
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F ig u r e  10 . P r e v io u s l y  f r o z e n  f e t a l  l iv e r  c e l l s  c a n  r e c o n s t it u t e  t h e
HAEMOPOIETIC SYSTEM OF LETHALLY IRRADIATED RECIPIENTS.
Freshly harvested and previously frozen (-70°C) fetal liver cells were used to 
reconstitute irradiated recipients. Donors: 3-83'^H2‘^ ‘* Ly-9.2/9.2, recipients: BALB/c- 
(H2‘^ "Ly-9.1/9.1).
A) B220^3-83^ cells are donor-derived transgenic B lymphocytes
B) B220* Ly-9.1 cells are donor-derived B cells, showing that the vast majority of B- 
lineage cells are donor-derived.
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As shown in Figure 10, using fetal livers cells carrying the 3-83 B cell receptor 
(BCR) transgene, frozen/thawed fetal livers are capable of reconstituting the 
lymphoid lineages of irradiated recipients as well as fresh fetal livers. We typically 
find that > 90% of B lineage cells in both bone marrow and spleen are derived from 
the injected donor fetal livers.
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F ig u r e  11 . C o m p a r is o n  o f  f e t a l  l iv e r  c e l l  n u m b e r s  b e f o r e  f r e e z in g  a t  - 7 0 °
C  AND AFTER THAWING.
Day 16.5 fetal livers were harvested, and cell numbers were determined on the same 
day ( ‘fresh’). Alternatively, fetal liver cell suspensions were frozen at -70°C (in 90% 
FCS + 10% DMSO) and kept up to 4 months before thawing ( ‘frozen’). Before 
freezing and after thawing cell numbers were determined using Casyton cell counter 
(using 4.8/xm -  15 (im diameter setting). Each symbol represents one fetal liver. 
Numbers shown are mean±SD (n=40) for both sets of samples.
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Freezing and thawing of fetal liver cell suspensions leads to a reduction in the number 
of viable cells, as determined by trypan blue exclusion or by Casyton cell counter.
We can recover on average 33.5±10.9 million cells from each previously frozen liver 
compared to 94.5±13.5 million cells harvested from fresh livers (Figure 11.). We 
have not observed any significant differences in cell recovery from fetal livers of 
different genetic make-ups (Syk°, Syk°ZAP-70°, Syk°Lyn°, etc.).
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4.2 Syk° Lyn° double mutant mice
One of the important group of tyrosine kinases shown to be involved in early 
signalling from the BCR is the Src family, with Lyn being its most prominent 
representative in the B lineage. Lyn has been implicated both as positive and 
negative regulator of B cell signalling (see Introduction). Gene targeted mutant Lyn° 
mice show reduced numbers of recirculating mature B cells, but development does 
not appear to be impaired at the pre-BCR checkpoint [137].
In order to examine the relative roles of Syk and Lyn in early B cell development, 
Syk° Lyn° double mutant mice were generated and analysed.
Comall et al. suggested that Lyn is not necessary for the initiation of BCR signalling, 
but may rather have an important negative effect [1 2 0 ], based on which one could 
have expected that the two mutations, Syk (positive regulator) and Lyn (negative 
regulator) neutralize each other, resulting in normal development. As discussed 
below, this does not appear to be the case.
4.2.1 B cell development in the absence of Syk and Lyn
The first question I wanted to address using Syk°Lyn° double knockout (DKO) mice 
was whether the incomplete block at the pro-B ^ p re -B  cell transition becomes more 
or less severe by removing Lyn in addition to Syk.
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Similarly to the Syk° animals, Syk°Lyn° mice also die around birth, therefore all the 
experiments used fetal liver radiation chimeras. Figure 12 shows the analysis of bone 
marrow B cell development in chimaeras in the presence and absence of Syk and Lyn.
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Chimaeric mice were generated using wild type, Lyn°, Syk° or Syk°Lyn° fetal liver 
cells as labelled. Ly-9.1- (donor-derived) bone marrow cells are shown. Numbers 
refer to percentages of Ly-9.1- cells falling into each quadrant.
Lyn° mice show lower percentages of recirculating mature B220“ cells as described 
[137], whereas Syk° B cells do not develop beyond the B220'°'^IgM^ stage as shown 
in Figure 9 (in the Introduction).
In the absence of both Syk and Lyn the ratio of B cells expressing IgM is further 
decreased, showing that without Syk and Lyn the pro-B^pre-B  block is more severe, 
but by no means complete.
45
The more severe phenotype of the Syk°Lyn° double-knockout compared to the single 
mutant animals suggests that Syk and Lyn play partially non-overlapping roles in B 
cell development, i.e. Lyn not only contributes to the activation of Syk, but also has 
Syk-independent functions.
4.2.2 Introduction of the 3-83 BCR transgene
Adding a pre-rearranged BCR transgene to single and double knockout animals by 
crossing them to mice carrying the 3-83 BCR transgene allows us to address the 
following questions:
-  Does a BCR transgene relieve the B cell developmental block seen in the single 
and double mutant non-transgenic mice?
-  Since this transgene was shown to effectively shut down endogenous 
immmunoglobulin gene rearrangement [53]: is allelic exclusion functioning in 
mice deficient in Syk and/or Lyn?
-  Is negative selection of autoreactive B cells intact in the absence of Syk and/or 
Lyn? The cognate ligand for the 3-83 BCR is known (MHC class IH-2K*'’'’), and 
can be carried by the chimera hosts.
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4.2.2A Effect of a rearranged transgene on B cell development
It has been shown for Syk° 3-83"  ^chimaeric mice [159] that B cell lineage cells in the 
bone marrow express IgM"" (the transgenic heavy chain), but only low levels of B220 
(see also Figure 13). No IgD expression is detected (not shown). Lyn° mice bearing 
the same 3-83 Tg express higher levels of B220 than their Syk° counterparts, but 
remain below that of the wild type mice. Few transitional cells (B220“ IgMa^ IgD^°) 
are also detected (not shown). Syk°Lyn° double knockout mice contain very few 
IgM^-expressing cells in their bone marrow, with very low B220-levels (Figure 13).
Addition of the anti-apoptotic regulator Bcl-2 as a transgene [162] increases the 
number of B220^ cells to reach same levels in all four genotypes, but B220 and IgM^ 
expression levels do not change significantly. The finding that in the presence of the 
Bcl-2 transgene the significant difference in B cell numbers between Syk° and 
Syk°Lyn° mice disappears, suggests that both Syk and Lyn have survival roles in 
early B cell development, and Lyn performs this role - at least to some extent - 
independently of Syk.
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MICE IN THE ABSENCE OF S yKAND/OR LYN.
Irradiated B10.D2 (H2' '^ )^ recipients were reconstituted with 3-83"  ^Ly-9.1/9.1 fetal 
liver cells of shown Syk/Lyn genotypes. 8  weeks later bone marrow cells were 
analysed. Cells were stained with anti-Ly-9.1 -FITC, anti-IgMa-PE and B220-APC. 
Plots shown are gated on Ly-9.L  donor-derived cells. Vertical lines divide IgMa^ 
andlgMa*® cells.
Survival, however, cannot be the only role for Syk and Lyn, given that addition of the 
Bcl-2 transgene does not lead to the appearance of fully mature B cells in these 
mutant mice.
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4.1.2.2 Allelic exclusion
The 3-83 Ig transgene carries IgK light chain, therefore any IgÀ expression on the cell 
surface must be due to endogenous light chain rearrangement. Figure 14. shows 
mildly increased IgÀ expression in Lyn° 3-83"  ^Bcl-2^ mice, while in Syk° 3-83"  ^Bcl- 
2^ bone marrow 20% of donor-derived B220^ cells coexpress IgMa and IgÀ. (Similar 
results were also obtained by M. Turner - unpublished). Even higher proportion 
(25%) of lambda expressing cells are found in Syk°Lyn° double knockout chimaeras.
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F ig u r e  14. E n d o g e n o u s  l i g h t  c h a in  r e a r r a n g e m e n t  i n  3-83 t r a n s g e n ic
MICE IN THE ABSENCE OF S yK.
Irradiated B10.D2 (H-2‘’^‘^ Ly-9.2/9.2) recipients were reconstituted with 3-83^
Ly-9.1/9.1 fetal liver cells of shown Syk/Lyn genotypes. 8  weeks later bone marrow 
cells were analysed. Cells were stained with anti-Ly-9.1-FITC, anti-IgMa-PE, biotin- 
anti-IgX/Streptavidin-Red613 and anti-B220-APC. Plots shown are gated on 
B220^Ly-9.L donor-derived B cells.
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Likewise, 8 % and 12% of donor-derived B cells also express endogenous heavy 
chain in Syk° 3-83+ Bcl-2+ and Syk°Lyn° 3-83+ Bcl-2+ mice, respectively (Figure 15).
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F ig u r e  15 . E n d o g e n o u s  h e a v y  c h a in  r e a r r a n g e m e n t  i n  3 -8 3  t r a n s g e n ic
MICE IN THE ABSENCE OF S yK.
Irradiated B10.D2 (H-2‘’^‘^ Ly-9.2/9.2) recipients were reconstituted with 3-83+ VL-2^  ^
Ly-9.1/9.1 fetal liver cells of shown Syk/Lyn genotypes. 8  weeks later bone marrow 
cells were analysed. Cells were stained with anti-IgM^-FITC, anti-IgM^-PE, biotin- 
anti-Ly-9.1/Streptavidin-Red613 and anti-B220-APC. Plots shown are gated on 
B220+ Ly-9.1+ donor-derived B cells.
Endogenous rearrangement resulting in cell surface expression of IgÀ and IgM’' in 
these 3-83 Ig transgenic mice could be explained by lack of allelic exclusion, 
suggesting that signals through both the pre-BCR and BCR to stop further 
immunoglobulin gene rearrangements are dependent on Syk and also on Lyn. That 
the Syk°Lyn° double knockout mice have higher percentages of B cells expressing
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the endogenous chains, would suggest that Lyn can act partly independently of Syk in 
this process. Bcl-2 transgene is needed to detect IgM’’ and IgX expression probably to 
allow these cells to survive long enough to complete the rearrangement and/or 
transcription/translation process.
4.2.2.3 Negative selection
I also wanted to analyse the role of Syk and Lyn in B cell development in the 
presence of the cognate ligand for the Ig transgene. The class I-reactive 3-83 
transgene has high affinity for H2-K’', lower for H2-K’’ and virtually none for H2-K‘’. 
To investigate potentially small, or stepwise changes brought about by changing 
levels of signalling molecules, H2’"’ background was used for which the transgene has 
rather low reactivity.
Analysis of IgM^ (transgenic heavy chain) expression is shown on Figure 16.
As expected, B220’“IgMa’“ and B220’’’lgMa’°IgD+ (not shown) cells are missing in the 
wild type and Lyn° chimaeras, due to receptor downmodulation. In all four 
genotypes we find similar levels of IgMa (IgMa’°) with intermediate expression of 
B220 in Wt and Lyn° and low levels of B220 in Syk° and Syk°Lyn° mice. These 
results suggest, that for deletion Syk and Lyn are dispensable.
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Irradiated (C57BL/10 x B10.D2)F1 Ly-9.2/9.2] recipients were reconstituted
with 3-83+ Ly-9.1/9.1 fetal liver cells of Syk/Lyn genotypes shown. 8  weeks
later bone marrow cells were analysed. Cells were stained with anti-Ly-9.1 -FITC, 
anti-IgM^-PE and B220-APC. Plots shown are gated on Ly-9.1+ donor-derived cells. 
Vertical lines separate IgMa’" and IgMa’° cells. See also Figure 13.
As mentioned before, in the anti-HEL/sHEL system Syk° B cells appeared to be 
hypersensitive to the cognate ligand, suggesting that Syk can also act as negative 
regulator [161]. Increased responsiveness in the absence of Syk would have resulted 
in lower levels of IgM" in the Syk°Lyn° double knockout bone marrow than in the 
others. On the contrary, if there is any difference in IgM" levels, than it is Lyn°<Wt 
= Syk° < Syk°Lyn°. This appears to be consistent with Lyn being a negative and Syk 
a positive regulator of BCR signalling in immature B cells (Figure 17).
(The IgMa’" cells detected in syk° and syk°lyn° chimaeras carrying the Bcl-2 
transgene are also expressing IgX, that renders them unresponsive to H2’’.)
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Irradiated (C57BL/10 x B10.D2)F1 Ly-9.2/9.2) recipients were reconstituted
with 3-83+ H-2‘’^‘’ Ly-9.1/9.1 fetal liver cells of Syk/Lyn genotypes shown. 8  weeks 
later bone marrow cells were analysed. Cells were stained with anti-Ly-9.1-FITC, 
anti-IgM"-PE and B220-APC. Plots shown are gated on (Ly-9.1+ B220+) cells. Mean 
fluorescence intensity of positive cells (black line) is shown. White bars added for 
easier comparison.
Interestingly, if we compare Figure 13 with Figure 16, we see significant expansion 
of IgMa’° cells in all four syk/lyn genotypes examined in 112’’"'’ chimaeras. In addition, 
the presence of Bcl-2 transgene further expands the IgMa+ cells in Syk° and in 
Syk°Lyn° chimaeras, mostly due to the expansion of IgÀ expressing cells. In the wild 
type (Syk+ '^Lyn+  ^) and Lyn° chimaeras, however, forced Bcl-2 expression leads to 
increased numbers of IgMa (also IgM b, not shown) cells at the expense of the IgMa 
expressing compartment.
One could speculate that the receptor levels on these IgMa’° cells are too low to signal 
differentiation/survival/expansion in H2 '’'’ mice, therefore they die of neglect. 
Increasing signal strength by providing a somewhat higher affinity ligand (H2-K’’) 
leads to their proliferation, but this signal is not appropriate (qualitatively or
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quantitatively) to induce differentiation. Cells with higher IgM" levels in the same 
environment would receive a strong enough signal for differentiation, resulting in 
upregulation of BCR on their surface, that strengthens the signal enough to cause 
negative selection.
Since the expansion of IgMa’° cells is seen in all four genotypes examined, this 
proliferative signal presumably does not require Lyn and Syk.
Preliminary experiments have shown that providing H2-K’' ligand for 3-83 transgenic 
cells (using H 2 ’"‘’ hosts in fetal liver radiation chimaera experiments) results in 
complete deletion of transgene bearing cells regardless whether Syk and/or Lyn is 
present (data not shown). This suggests that strong signals can induce negative 
selection mediated by Syk and/or Lyn independent pathways.
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4.3 Syk and ZAP-70 in B cell development
Gene targeted mutant mice have frequently revealed redundancies among signal 
transduction molecules known to perform similar functions [163]. Syk protein 
tyrosine kinase also has a ‘sibling’, ZAP-70, and these two family members have 
been observed to compensate for each other’s absence [164-166]. ZAP-70, however, 
has only been shown to be expressed in T cells and NK cells, and has never been 
detected in B lineage cells. In light of the phenotype of Syk° animals - B cell 
development is severely, but incompletely blocked at the pro-B pre-B checkpoint 
(Figure 9 in Introduction and [127,128]) - I intended to revisit this issue. In order to 
conduct the genetic experiment Syk° and ZAP-70° [167] gene targeted mutant mice 
were inter-crossed, to generate ‘double knockout’ (DKO) animals lacking both 
members of the Syk/ZAP-70 family.
As expected - and similarly to the single mutant animals only missing Syk -, the 
double mutation also leads to perinatal lethality. While T cell development in DKO 
mice can be and has been studied in newborn mice [165], for the analysis of B cell 
development, fetal liver radiation chimaeras were needed.
Day 16.5 fetal liver cells from wild type (Syk+ZAP-70+'+), Syk° (Syk'^' ZAP-70+^+), 
ZAP-70° (Syk+ ZAP-70 '^) and DKO (Syk'^'ZAP-70'^ ) embryos were injected into 
lethally irradiated recipients. The resulting chimaeric mice were analysed 8-12 weeks 
after transfer. To also make use of the 3-83 transgene (see below) and to differentiate 
between donor- and host-derived B lineage cells, all the donor mice were on H2^^,
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Ly-9.2/9.2, IgH ’’^  background (backcrossed 6  generations unto B10.D2), whereas the 
recipients were or Ly-9.1/9.2, IgH"^ ((BALB/c x B10.D2)F1 or (BALB/c 
X C57BL/10)F1) mice.
These chimaeras confirmed the T-cell development phenotype seen in intact newborn 
animals [165] : in the absence of Syk and ZAP-70 thymocyte development is 
arrested at the pre-TCR checkpoint, resulting in a block at the CD4 CD 8 ' , DN3 stage 
(Figure 18), similarly to RAG-1° mice. This phenotype demonstrates that Syk and 
ZAP-70 perform essential but overlapping functions at the pre-TCR checkpoint.
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AT CD4 S  STAGE
Thymi from chimeric mice generated from fetal livers of the shown genotypes are 
compared. Plots show Ly-9.1' thymocytes labelled with anti-CD8  and anti-CD4 
antibodies. Numbers within plots refer to percentage of Ly-9.1 thymocytes falling 
into each quadrant. Numbers above plots show total thymocyte numbers in millions 
of cells.
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4.3.1 B cell development in the absence of Syk and ZAP-70
As reported before [159] and also shown in Figure 9, in the absence of Syk kinase B 
cell maturation appears to be blocked at two developmental checkpoints: ( 1 ) 
incompletely at the pre-BCR checkpoint, resulting in generation of lower numbers of 
pre-B cells, and (2) completely at the immature —> mature transition, resulting in the 
absence of mature B lymphocytes in these animals.
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Fetal liver radiation chimaeras were generated using day 16.5 fetal livers of the four 
shown genotypes. 8 - 1 2  weeks after cell transplantation bone marrow cells were 
harvested. Ly-9.1' donor-derived cells are shown that were stained with anti-B220 
and anti-IgM. Numbers refer to percentage of Ly-9.1' bone marrow cells falling into 
each quadrant.
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Similar phenotypic analyses were performed on the DKO (Syk°ZAP-70°) chimaeric 
mice to determine whether removal of the other Syk/ZAP-70 family member changes 
the developmental pattern of B lymphocytes.
Figure 19 shows that while ZAP-70° chimaeras show normal B cell development, 
removal of ZAP-70 in addition to Syk has a surprisingly strong effect on B cell 
development: in the DKO chimaeric animals no IgM expressing donor-derived bone 
marrow cells develop, resulting in a complete lack of immature and mature B cells.
Further analysis of surface marker expression shows that in DKO mice B cell 
maturation is completely blocked before the pre-B cell stage. Figure 20 shows 
expression of CD2 on B lineage donor-derived cells, using CD 19 as a marker this 
time to limit our analysis to B lineage cells, especially since CD2 is not restricted to B 
lymphocytes. CD2 is not detectable on pro-B cells, but is expressed on pre-B, 
immature and mature B cells, and as such is a valuable marker of cells that 
successfully passed the pre-BCR checkpoint. The lack of expression of CD2 on DKO 
CD 19^ bone marrow cells suggest that without Syk and ZAP-70 B cells cannot 
transmit signals from the pre-BCR for developmental progression.
Further phenotypic analysis in Figure 21 shows that DKO B lineage bone marrow 
cells are arrested at the CD19+CD43+ large pro-B cell stage. In comparison, a 
quarter of single knockout Syk° B cells are CD43- and smaller in size, confirming 
again that ZAP-70 is partially compensating for the lost Syk function at the pro-B —> 
pre-B transition.
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As in Figure 19, plots show donor-derived Ly-9.1 bone marrow cells. Numbers refer 
to percentage of donor-derived CD 19^ bone marrow cells that do or do not express 
CD2, respectively.
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(top panel) FSC/SSC analysis of all donor-derived B lineage bone marrow cells. 
Numbers shown refer to percent of cells displaying FSC^^SSC^^ and FSC'°'^SSC'“'^  
phenotypes.
(middle panel) FSC*“®^ SSC“^^  cells gated as shown on the top panel, then CD19/CD43 
expression displayed. Numbers shown refer to percentage of cells in the 
CD19+CD43+'^"' quadrant;
(bottom panel) FSClowSSClow cells gated as shown on the top panel, then 
CD19/CD43 expression displayed. Numbers shown refer to percentage of cells in the 
CD19^CD43'^°'^ quadrant. No difference has been seen between wild type and ZAP- 
70° animals.
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Donor-derived (Ly-9.1') CD 19^ B cells are subdivided into pro-B cells (CD2'IgM ), 
pre-B cells (CD2^ IgM ) and IgM"  ^cells. Values refer to percentage of CD 19^ donor- 
derived cells falling into each subpopulation. Filled circles show individual chimeric 
mice, while columns show average values for each group. Below each column mean 
percentages are shown, with standard deviations and the number of mice analysed.
The above results suggest that in the absence of Syk and ZAP-70 B lymphocytes 
cannot progress beyond the CD 19^CD43^CD2 IgM pro-B cell stage. The question 
arises whether these cells are capable of producing a pre-BCR, but incapable of 
transducing the signal emanating from this receptor, or whether these cells are 
impaired at an earlier stage and cannot even produce a pre-BCR. To distinguish 
between these two possibilities intracellular heavy chain expression was analysed.
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As shown in Figure 23, pro-B cells in the absence of Syk and ZAP-70 are capable of 
expressing heavy chain in their cytoplasm. The proportion of DKO cells with [i chain 
in their cytoplasm, however, stays well below that of Syk° single mutant mice. A 
likely explanation for this difference is that, as seen above, a portion of Syk° B 
lymphocytes do reach the pre-B/immature stage, providing these mice with an 
opportunity to expand their pre-B cells with a productive/functional heavy chain. In 
contrast, if the DKO mice are incapable of transmitting a pre-BCR signal, as the 
phenotypic analysis leads us to think, there would be no selective proliferation of 
cells with productive heavy chain rearrangement.
Detection of [i heavy chain protein in the cytoplasm of DKO pro-B cells also suggests 
that heavy chain rearrangement, including locus accessibility and rearrangement 
initiation is unimpaired in the absence of Syk and ZAP-70 (see analysis of 
rearrangement later in this chapter). This phenotype is different from the one seen in 
Igp° mice, where DJ^, but not VDJ^ rearrangement in seen [10]. This difference 
would imply that while we propose that Syk/ZAP-70 is crucial in transducing signals 
from the pre-BCR that supposedly would also involve Igp, earlier in development Igp 
may function without Syk or ZAP-70.
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Plots show Ly-9.1' B220^°'  ^IgM' donor-derived pro- and pre-B cells from chimaeric 
mice. Numbers refer to percentage of cells showing intracellular heavy chain 
expression. As a negative control, RAG-1° pro-B cells are shown.
In addition to the /x heavy chain, X5 and Vpre-B must also be present for successful 
pre-BCR assembly. Figure 24 shows that both of the surrogate light chain 
components are detected on the surface of B lineage cells in the absence of Syk
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and/or ZAP-70. In fact, most of the CD 19^ cells in Syk° and Syk°ZAP-70° mice 
express X5 and Vpre-B after 1 hour incubation at 37°C, further emphasizing the lack 
of progression beyond the pre-BCR stage.
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Bone marrow cells from chimeric mice generated with Wt, ZAP-70°, Syk° and 
Syk°ZAP-70° fetal livers were incubated at 37°C for 1 hour before staining. Donor- 
derived CD 19^ cells are shown. As control, CD 19^ bone marrow cells from intact 
RAG-1° animals are also shown.
4.3.2 Cell-autonomous effect of Syk and ZAP-70 deficiency
Results presented above show that ZAP-70 and Syk are required within haemopoietic 
cells for the pro-B —>pre-B transitions. One possible explanation could be that ZAP- 
70 can affect B cell development in trans, i.e. ZAP-70 is not required in B lineage 
cells themselves, but rather in another cell type that can influence the maturation of B 
cells, for example by secreting a cytokine, or expressing a surface protein that can
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interact with the B cell precursors. To confirm or exclude this possibility, mixed
radiation chimaeras were generated.
4.3.2.1 Generation o f mixed radiation chimaeras
As Figure 25 schematically depicts, by mixing Syk° and Syk°ZAP-70° donor fetal 
liver cells, development of B cells from Syk° precursor with or without ZAP-70, 
respectively, can be studied in the same animals. If ZAP-70 has a cell-autonomous 
role, i.e. is needed within the developing B lineage cells themselves, the observed 
differences in B cell maturation between Syk° and DKO animals should also be seen 
in the mixed chimaeras. If, however, ZAP-70 acts in trans, all B cells should develop 
as they do in Syk° mice, since there is ZAP-70 expression in other (non-B) 
haemopoietic cells contributed by the Syk° fetal liver.
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Fetal livers were harvested as before. The two different donors (Syk° and Syk°ZAP- 
70°) and the host can be distinguished by a combination of Ly-9.1 and H2 expression. 
In the host only a few mature B lineage cells survive long-term following the 
irradiation. These express high levels of H2^ and high levels of Ly-9.1, enabling us to 
exclude them from the analysis of B lineage cells of donor origin(s).
66
4.S.2.2 Results from mixed radiation chimaeras
As seen in Figure 19 and Figure 20 the incomplete vs. complete block in B cell 
maturation in Syk° mice in the presence or absence of ZAP-70, respectively, can be 
reliably characterised by IgM and CD2 expression on B lineage bone marrow cells: 
both IgM and CD2 can be found on a portion of Syk° B cells, whereas neither of 
these two markers are expressed on DKO cells.
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(top) chimaeras generated with unmixed fetal liver cells as donors 
(bottom) two examples of mixed chimaeric mice
Plots show donor-derived CD 19^ cells - host cells (Kb"^ , Ly-9.1^^) are excluded from 
the analysis.
Numbers shown represent percentage of CD 19  ^cells of (each) donor origin 
expressing IgM.
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Figure 26 and Figure 27 show analyses of IgM and CD2 expression on the B lineage 
cells in the bone marrow of mixed radiation fetal liver chimaeras, respectively. The 
chimaeras shown were generated by mixing equal numbers of fetal liver cells from 
the two donor genotypes. Similar results were seen using 90%-10%, 75%-25%, 25%- 
75% and 10%-90% mixtures, as well.
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See Figure 26.
Numbers shown represent percentage of CD 19  ^cells of (each) donor origin 
expressing CD2.
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Both Figure 26 and Figure 27 reveal the same outcome for the experiment: the 
differences in IgM and CD2 expression seen in the non-mixed chimaeras (top panels) 
can still be observed after mixing the two donor fetal liver population (bottom 
panels). These results confirm that ZAP-70 must be expressed within the B lineage 
cell themselves in order to allow progression beyond the pre-BCR checkpoint in the 
absence of Syk, since ZAP-70 expressing non-B lineage haemopoietic cells provided 
by the Syk° (ZAP-70' '^'^) fetal liver cannot rescue the complete developmental block in 
DKO B cells.
Mixed chimaeras were also generated using wild-type/Syk° and wild-type/Syk°ZAP- 
70° fetal liver cell mixtures. Not surprisingly, however, B lineage cells developing 
from the wild type donor outcompeted the mutant precursors resulting in no 
detectable B lineage cells of mutant donor origin. I was, therefore, unable to analyse 
the developmental progression of the mutant cells in these chimaeras. Whether this is 
due to defective expansion of the mutant B cells after the pre-BCR checkpoint would 
need further investigation.
4.3.3 ZAP-70 protein expression in B lineage cells
Results from the mixed fetal liver radiation chimaera experiments (Figure 26 and 
Figure 27) strongly suggest that ZAP-70 must be expressed by the B lineage cells 
themselves. Formally the mixed chimaera experiment shows that ZAP-70 is required 
cell autonomously within the lineage leading to pro-B cells, but it might be required
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not in the pro-B cell itself, but at an earlier stage, e.g. in the hemopoietic stem cell.
To differentiate between these possibilities, ZAP-70 protein expression was analysed 
by Western blotting experiments.
I wanted to examine protein expression in B lineage cells of different maturational 
stages. Special emphasis was put on pro-B cells for the following reasons:
(1) Due to the complete block at the pro-B-^pre-B transitional step, analyses of DKO 
chimaeric mice (above) have only addressed the overlapping function of Syk and 
ZAP-70 in pro-B cells.
(2) Syk expression has been reported to be downregulated upon pre-TCR signalling in 
developing thymocytes [168]. If a reciprocal situation were to be true in B lineage 
cells, one might expect downregulation of ZAP-70 in pre-B cells relative to pro-B 
cells.
(3) Syk° mutant mice show complete block at the immature—^ mature B cell transition 
[127, 128], suggesting that ZAP-70, even if expressed in immature B cells, cannot 
efficiently substitute for the missing activity of Syk.
(4) No impairment of mature B cell function has been described in ZAP-70° animals. 
Based on this, if ZAP-70 is expressed in B lineage cells, it might be most abundant in 
pro-B cells.
4.3.3.1 Sorted population ofB  lineage cells for analysis
The most informative protein expression analysis would have been done using flow 
cytometry and detecting intracellular ZAP-70 expression at a single cell level. My
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attempts using four different anti-ZAP-70 antibodies, and different intracellular 
staining methods, however, failed to detect any ZAP-70 expression even in 
thymocytes or mature T cells. I resorted, therefore, to Western blot analysis of 
protein expression.
Since Western blotting detects protein expression in bulk cell populations without the 
possibility of extrapolating expression levels in single cells, cell samples used had to 
be homogenous, and most importantly, devoid of non-B lineage cells. FACS sorting 
was therefore performed to obtain pure pro-B, pre-B and peripheral B cells.
As a source of pro-B cells RAG-1° bone marrow cells were used, where B cell 
differentiation is blocked at the pre-BCR step owing to the absence of Ig heavy (and 
light) chain rearrangement [7]. Since CD2 expression starts only in pre-B cells, cells 
were sorted using anti-CD 19 and anti-CD2 antibodies. Pro-B cells collected were 
96% CD19+CD2 .
Pre-B cells were sorted from the bone marrow of RAG-1° mice carrying the HC186, 
heavy chain only transgene that drives differentiation of B lineage cells through the 
pre-BCR signalling stage, and allows the accumulation of-pre-B cells. These cells 
cannot, however progress any further in the absence of light chain rearrangement 
[169]. Pre-BCR can be expressed in these mice, but the levels are too low to be 
detected by our anti-ju antibody. Cells were sorted using anti-CD 19 and anti-CD2 
antibodies. Pre-B cells collected were 98% CD19^CD2^.
Peripheral B cells were sorted from spleens of wild type mice using only CD 19 as a 
marker of B cells, therefore these samples contain all subpopulations of B 
lymphocytes found in murine spleen, including immature, transitional, recirculating 
mature follicular and marginal zone B cells. Cells collected were 99% C D 19\
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T lineage cells are known to express ZAP-70, therefore total thymocytes from wild 
type and ZAP-70° mice served as a positive and negative control, respectively.
4.3.3.2 Western blot analysis
As predicted by the mixed chimaera experiments and shown in 
Figure 28, ZAP-70 expression can indeed be detected in B lineage cells. Analysing 
graded numbers of cells or graded amounts of protein suggests that the difference 
between the two lineages is less than expected. Pro-B cells express 3-5-fold less 
ZAP-70 than total thymocytes, whereas expression in pre-B cells is a further 3-fold 
lower. In contrast, peripheral B cells show comparable expression to pro-B cells.
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Cytoplasmic lysates were prepared from sorted B cell populations and unsorted total 
thymocytes. The numbers above each lane refer to the number of cells analysed.
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4.3.4 Syk/ZAP-70 function in pro-BCR/pre-BCR signalling in vivo
The above mixed chimaera and western blot experiments demonstrate that ZAP-70 is 
expressed in the B lineage of mice. These results raise the question whether ZAP-70 
is functional in B lymphocytes.
In the absence of ZAP-70, Syk appears to be sufficient for unimpaired B lymphocyte 
development and function, serving as a warning that in the presence of Syk, ZAP-70 
activity might be difficult to assess. A more suitable system for this purpose, 
therefore, would be provided by the Syk° mice, with or without ZAP-70 expression, 
respectively.
As shown before (Figure 20), in the absence of Syk and ZAP-70, B lymphocyte 
development is arrested at the pro-B cell stage. Hence the only B lineage cells that 
we can identify and analyse for ZAP-70 function in these mice are pro-B cells.
As Figure 23 displays, these pro-B cells are capable of synthesizing p  heavy chain, so 
we can assume that at least a fraction of them can also express pre-BCR (p heavy 
chain in complex with the surrogate light chain) on their surface.
In addition, a fraction of these pro-B cells would also express the ‘pro-BCR’, Ig(x/|3 in 
complex with calnexin [1 1 , 1 2 2 ].
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In order to study signal transduction through these receptors, one can take advantage 
of a recently described system [122] [133], that uses anti-Igp antibody to crosslink the 
Igp component of these receptors and induce signalling.
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F ig u r e  29. HM79 (a n t i - I g P ) t r e a t m e n t  in d u c e s  d if f e r e n t ia t io n  o f  RAG-1 ° 
p r o -B  c e l l s
RAG-1° mice were injected intraperitoneally with 1 mg purified HM79 (anti-Igp) 
antibody, with 0.5 mg 2C11 (anti-CD3) antibody (both in 400/xl volume), or with 400 
jitl PBS. 9 days later bone marrow from these mice were analysed. Numbers show 
percentage CD2^ cells among CD 19  ^bone marrow cells.
As reported, and also shown on Figure 29, intraperitoneal injection of 1 mg purified 
HM79 (anti-IgP) antibody induced differentiation of RAG-1° pro-B cells 
characterised by induction of e.g. CD2, CD25 and increased BP-1 expression. In 
contrast, i.p. injection of anti-CD3E (2C11) had no effect on B cell development in 
RAG-1° mice.
2C11 (anti-CD3e) was chosen as negative control not only because it is a hamster- 
anti-mouse antibody as is HM79, but also because it has been shown to induce 
differentiation of RAG° thymocytes [123], thereby performing a potentially
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analogous function in the T-lineage to that of HM79 in the B-lineage. This well- 
characterised effect of 2C11 on RAG° thymocytes serves as a useful control: it 
confirms the effectiveness of the injected 2 C 1 1  and shows the specificity of both 
antibodies (Figure 30).
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DIFFERENTIATION OF RAG-1° THYMOCYTES
See legend to Figure 29. 9 days after i.p. injections thymi were analysed. Numbers 
within each plot represent percentage of thymocytes falling into each quadrant. 
Numbers above plots show total thymocyte cell numbers in millions.
Figure 29 and Figure 30 confirm reported findings: HM79 (anti-IgP) can induce 
differentiation of RAG-1° pro-B cells, presumably by crosslinking the IgP component 
of the pro-BCR, whereas this antibody has no discernible effect on thymocyte 
differentiation in RAG-1° mice. 2C11 (anti-CD3) on the other hand induces 
developmental progression of RAG° pro-T cells and an increase in thymocyte cell 
number presumably by stimulating the clonotype-independent CD3 complex (CIC). 
However, it does not affect B cell development in RAG-1° mice.
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In order to assess the functionality of ZAP-70 in the B lineage, the effect of HM79 
injection on Syk°ZAP-70° pro-B cells was determined. Radiation fetal liver 
chimaeras were generated as before, using Syk° or Syk°ZAP-70° fetal livers as 
donors, injected with 1 mg purified HM79 intraperitoneally and compared with 
similarly treated intact RAG-1° animals.
Figure 31, Figure 32 and Figure 33 show analyses performed 13 days after antibody 
injections. Similar data were obtained 7 and 9 days after injections (not shown).
As seen before, RAG-1° pro-B cells can be induced to differentiate into CD2 and 
CD25 expressing ‘pre-B-like’ cells. BP-1 expression is also detectable on a higher 
percentage of cells. HM79 injections do not induce differentiation of all RAG-1° pro- 
B cells, probably because not all cells express the pro-BCR at the same time and at 
the same level and also because new pro-B cells are continuously generated.
In contrast to RAG-1° animals, HM79 injections do not have any effect on CD2, 
CD25 and BP-1 expression on Syk°ZAP-70° pro-B cells. As mentioned above, these 
pro-B cells can potentially express pro-BCR and pre-BCR, as well -  though not 
necessarily at the same time. This result shows that without Syk and ZAP-70 these 
receptors cannot transmit a differentiation signal, suggesting that ZAP-70 can 
transduce signals from either the pro-BCR or pre-BCR in B lineage cells.
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F i g u r e  3 1 . HM 79 in d u c e s  d if f e r e n t ia t io n  o f  RAG-1 ° b u t  n o t  Syk°ZAP-70° 
p r o -B  c e l l s  (1)
Radiation fetal liver chimaeras were generated as before, using Syk° or Syk°ZAP-70° 
fetal livers as donors (all Ly-9.2/9.2, H2^^), and 129/Sv (Ly-9.1/9.1, H2^^) mice as 
lethally irradiated recipients. 8  weeks after cell transplantation chimaeras and intact 
RAG-1° (Ly-9.2/9.2, mice were injected intraperitoneally with either 400^1 
PBS or 1 mg purified HM79 in 400 fi\ volume. 13 days later mice were sacrificed 
and bone marrow cells analysed. Plots show Ly-9.1' (donor-derived) bone marrow 
cells. Numbers refer to percentages of Ly-9.1 CD 19^ cells expressing CD2.
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p r o -B  c e l l s  (II) See legend to Figure 31.
Syk°ZAP-70°
1....1,1 "IIIIII
10' 10  ^ 10
   I 1 INIII
, .     .
10" 10 ' 10  ^ 10'^  100 "  010"  10 10"  10 0 "  0
PBS
HM79
F ig u r e  3 3 .  HM79 i n d u c e s  d if f e r e n t ia t io n  o f  RAG-1 °  b u t  n o t  Syk°ZAP-70° 
p r o -B  c e l l s  (HI) See legend to F ig u re  31.
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Syk° chimaeric mice were also injected with HM79 and analysed. These mice have a 
more complicated receptor makeup. B lineage cells in Syk° bone marrow can 
potentially express pro-BCR, pre-BCR, and some of them also express a ‘real’ BCR. 
The predicted effects of IgP crosslinking, therefore could be induced differentiation 
(through pro-BCR and pre-BCR), proliferation (via pre-BCR) and negative 
selection/deletion (via BCR). As Figure 34 shows there is a trend for loss of CD2 
expressing cells in HM79-injected Syk° chimaeras, suggesting that deletion 
dominates. There is, however, large variability among the mice analysed.
An even more controlled experiment is currently in progress to assess whether ZAP- 
70 can play a role in (early) B cell signalling: three types of chimaeric mice are being 
generated, RAG-1°, Syk° RAG-1° and Syk°ZAP-70°RAG-l°. B cell development is 
expected to be blocked at the pro-BCR stage in all three types of mice. They are all 
expected to express only the pro-BCR, so IgP injections would reveal the importance 
of Syk/ZAP-70 in pro-BCR signalling.
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F ig u r e  34 HM79 in d u c e s  d if f e r e n t ia t io n  o f  RAG-1 °  b u t  n o t  Syk°ZAP-70° 
p r o -B  c e l l s  (IV)
See legend to Figure 31. Each symbol represents an individual mouse. Data from 
analyses 7, 9 and 13 days after antibody injection are combined. Below each group of 
mice mean values, standard deviation and number of mice analysed are shown.
Values for RAG° and Syk°ZAP-70° mice were also analysed by the Mann-Whitney 
test. Significant differences are shown by the asterisk.
Figure 35 shows another control for the above experiments. Similarly to the results 
seen in Figure 30, injection of HM79 does not affect T cell differentiation in Syk° or 
Syk°ZAP-70° mice.
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See legend to Figure 31. Ly-9.1' donor-derived thymocytes are shown. Numbers 
within each plot represent percentage of thymocytes falling into each quadrant. 
Numbers above plots show Ly-9.1' thymocyte cell numbers in millions.
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4.3.5 Introduction of the 3-83 BCR transgene
Intracellular heavy chain expression in Syk°ZAP-70° pro-B cells (Figure 23) suggests 
that immunoglobulin heavy chain rearrangement can proceed in the absence of 
Syk/ZAP family protein kinases at least to some extent. Introduction of a pre­
rearranged BCR transgene that bypasses the need for endogenous recombination is a 
useful tool to probe for any rearrangement deficiencies. The 3-83 BCR transgene 
[59] was chosen (see also: Syk/Lyn chimaeras), since it allowed us to analyse not 
only B cell development across the pre-BCR checkpoint and associated allelic 
exclusion, but also negative selection, since the cognate ligand (MHC class I, H- 
2 K^ ''") is easily introduced into our chimaeric system.
4.3.5.1 Effect o f a rearranged transgene on B cell development in the absence of 
Syk and ZAP-70
As seen in Figure 19, no IgM-expressing cells develop in the bone marrow of DKO 
(Syk° ZAP-70°) mice. In contrast. Figure 36 shows that a pre-rearranged BCR that is 
introduced as a transgene can be easily detected on the surface, suggesting that the 
lack of IgM expression in non-transgenic mice is not due to any problems related to 
problems with carrying the protein on the surface (e.g. lack of stabilizing components 
[Iga/p], enhanced internalization etc.).
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F i g u r e  36, T r a n s g e n ic  (3-83) BCR is  e x p r e s s e d  o n  t h e  s u r f a c e  o f  Syk°ZAP- 
7 0 °  BONE MARROW CELLS
Plots show Ly-9.1' (donor) gated bone marrow cells. Top panels: Non-transgenic 
chimaeric mice. Anti-IgM antibody used (b7.6) recognises all IgM allotypes. Bottom 
panels: Chimaeric mice generated using 3-83 BCR transgene-carrying fetal liver cells. 
Anti-IgM^ binds to the transgene-encoded BCR. All donors are Ly-9.2/9.2, H2‘^ ‘*, 
IgH^^, the transgene is IgH% the recipients are Ly-9.1/9.2, H2‘^ ‘^, IgH ^. Numbers 
refer to percentage of Ly-9. T bone marrow cells falling into each quadrant.
Levels of BCR expression on DKO B lineage cells are lower than on wild type cells. 
Also, B220^^^ cells can only be detected wild type, but not Syk° or Syk°ZAP-70° 
mice. These findings raise the question about the maturational stage of cells 
expressing the transgenic BCR in the single and double knockout animals.
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Given that no B220“^  cells were found in the knockout animals, suggesting that Syk° 
and Syk° ZAP-70° B lineage cells do not reach the recirculating mature stage, it is not 
surprising that no IgD expression can be detected on the transgenic BCR-carrying 
(IgM^^) cells (Figure 37).
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Plots show Ly-9.1 B220^ donor-derived B lymphocytes from bone marrow of 
chimaeric mice. IgM^ identifies B cells expressing transgene-encoded BCR on the 
surface. Numbers refer to percentage of Ly-9.1' B220^ cells falling into each 
quadrant.
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To further assess whether introduction of a BCR transgene lead to any developmental 
progression in Syk°ZAP-70° pro-B cells, CD2, CD25 and CD43 expression was 
analysed in these mice (Figure 38).
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Bone marrow cells from non- 
transgenic (left column) and 
3-83 BCR transgenic (right 
column) Syk°ZAP-70° 
chimaeric mice are compared. 
Plots show Ly-9.1- (donor- 
derived) bone marrow cells.
CD2 and CD25 expression starts in pre-B cells. The absence of both of these markers 
from both non-transgenic and 3-83 transgenic Syk°ZAP-70° cells suggests that B cell 
development has not progressed beyond the pro-BCR stage. This is confirmed by the
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expression levels of CD43: all CD 19^ (B-lineage) bone marrow cells express CD43, a 
marker of pro-B cells, which is turned off as cells mature into pre-B cells.
The fact that introduction of a pre-rearranged BCR transgene does not influence the 
developmental block seen in the absence of both Syk and ZAP-70, and that (as seen 
in Figure 23) Syk°ZAP-70° pro-B cells can express intracellular heavy chain suggest 
that the developmental arrest is not due to a defect in immunoglobulin heavy chain 
rearrangement, but rather to a signalling defect from the pre-BCR. This also 
suggests, that if there is any signal needed to initiate rearrangement (e.g. from IgP, as 
suggested by the Igp-deficient mice[10]), that signal is independent of Syk/ZAP- 
family of protein tyrosine kinases.
4.3.5.2 Allelic exclusion
One of the important tasks a pre-BCR has to accomplish is to establish allelic 
exclusion at the heavy chain locus, which ensures that a developing B cell only 
expresses one heavy chain protein on the surface. Introduction of a BCR transgene 
allows for an easy assay of this process: since this BCR comes on early in 
development, it stops all endogenous heavy (and light) chain rearrangement as 
detected by surface expression or by DNA recombination.
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4.3.5.2.1 Cell surface receptor expression
4.3.S.2.1.1 Heavy chain expression
The heavy chain construct used for the generation of the 3-83 transgene is derived 
from BALB/c (Igff) mice, therefore it can be distinguished from the B10.D2 (IgH*’) 
derived endogenous heavy chain locus by allotype-specific antibodies. As previously 
described [53] and seen in Figure 39, wild type mice carrying the 3-83 transgene do 
not express fi heavy chain encoded by the endogenous IgH^ locus, showing intact 
allelic exclusion. In contrast, in the absence of Syk and ZAP-70, a sizeable portion of 
IgM^ expressing cells also expresses IgM^ chain, demonstrating a failure of allelic 
exclusion.
This experiment suggests that without Syk and ZAP-70, the allelic exclusion process 
is incomplete, showing that at least this aspect of pre-BCR signalling is dependent of 
Syk and/or ZAP-70.
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Plots show Ly-9.1 CD 19^ donor-derived B lineage cells from bone marrow samples 
of chimaeric mice reconstituted with fetal liver cells from Wt, Zap-70°, Syk° and 
Syk°ZAP-70° embryos, respectively, all carrying the 3-83 BCR transgene. IgM^ is 
the heavy chain allotype of the transgene, whereas IgM^ is the endogenous heavy 
chain allotype. Numbers represent percentage of double-expressors among IgMa+ 
cells.
43.5.2.1.2 Light Chain expression
The 3-83 transgene encodes not only a /x/5 heavy chain, but also a K light chain. 
While the pre-BCR (heavy chain plus surrogate light chain) ensures allelic exclusion 
at the heavy chain locus, the BCR (heavy chain plus conventional light chain) stops 
endogenous light chain rearrangement, k  exclusion is difficult to assess by FACS
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analysis, since anti-K antibodies cannot differentiate between the transgenic and 
endogenous k  chains. A good marker for light chain allelic exclusion in this case is 
expression of X light chain, since that must be encoded by the endogenous locus.
Figure 40 shows endogenous X expression in transgenic mice. Less than 1% of the 
IgM^-expressing cells show X expression confirming the existence of allelic exlusion 
in these transgenic mice. In contrast to the heavy chain results (Figure 39) there is 
less, rather than more X expression in the absence of Syk and ZAP-70. This result 
could suggest perfect light chain allelic exclusion without Syk and ZAP-70, however, 
a more likely explanation is that Syk°ZAP-70°3-83^ cells are still pro-B cells (as seen 
in Figure 38), and have not received any signals initiating light chain 
rearrangement/expression. DNA analysis (see below) could confirm this possibility.
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Plots show Ly-9.1- B220+ donor-derived B lineage cells from bone marrow samples 
of chimaeric mice. IgMa is the heavy chain allotype of the transgene, 1 denotes 
endogenous light chain expression. Numbers represent percentage of B220+ Ly-9.1- 
cells falling into each quadrant.
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4.3.S.2.2 Rearrangement of immunoglobulin heavy chain g en es
DNA rearrangement analyses in Syk°ZAP-70° mice could answer the following 
questions:
-  do VDJh rearrangements of the heavy chain locus use 3’ as well as 5’ Vh 
families, suggesting that the initiation of rearrangement/locus accessibility is 
intact in these mice?
-  is VDJh rearrangement detectable in 3-83‘^ Syk°ZAP-70° mice confirming the 
lack of allelic exclusion at the heavy chain locus?
43.5.2.2.1 Bulk fetal liver PCR
Bulk fetal liver DNA was analysed for heavy chain rearrangement. To assess usage 
of 5’ Vn-families, which is impaired in IL-7Ra° mice [12], VDJ rearrangement using 
V-segments from the VhJ558 family was analysed. As shown in Figure 42, all non- 
transgenic samples show rearrangements, suggesting that no signal through Syk 
and/or ZAP-70 is needed for the initiation and completion of heavy chain 
rearrangements.
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F i g u r e  41 . U n im p a ir e d  h e a v y  c h a in  r e a r r a n g e m e n t s  i n  t h e  a b s e n c e  o f  S y k  
AND ZAp-70
DNA from day 16.5 fetal liver cells was prepared and analysed by PCR using 
upstream primers for (top panel) VyJ558 and (bottom panel) Dp /^spi families in 
combination with downstream primers hybridizing downstream of JH4 . DNA from 
20,000 (lane 1,5,9,13), 4,000 (lanes 2,6,10,14), 800 (lanes 3,7,11,15) and 160 (lanes 
4,8,12,16) cell-equivalents was used. PCR products were analysed on agarose gel, 
transferred onto nylon membrane and hybridized with a probe encompassing JH3.4 .. 
RAG-1° fetal liver DNA was used as negative control.
Transgenic samples allow the evaluation of allelic exclusion in the presence and 
absence of Syk and/or ZAP-70. Figure 42 shows VDJ rearrangement in Syk° and 
Syk°ZAP-70°, but not in wild type or ZAP-70° transgenic samples, showing impaired
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allelic exclusion in the absence of Syk and/or Zap-70. DJy rearrangements serve as 
control showing that there is DNA in the samples analysed and that allelic exclusion 
stops V-DJji but not D-Jy recombinations. These results are consistent with the 
FACS-analysis shown before (Figure 39): Syk and/or ZAP-70 is needed for complete 
allelic exclusion at the heavy chain locus.
Wt ZAP.70" S yk
Syk"
ZA P-70
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
All 3 -83+
V h J 5 5 8  -  D J h
VDJ„1
VDJ„2
VDJ„3
VDJ„4
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DJ„2
DJw3
—  DJ„4
F i g u r e  4 2 . L a c k  o f  i m m u n o g lo b u l in  h e a v y  c h a in  a l l e l i c  e x c l u s i o n  i n  t h e  
ABSENCE OF SyK A N D  Z A P -70
See legend to Figure 41. All samples from embryos carrying the 3-83 BCR 
transgene.
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43.5.3 Negative selection
Previous analyses of negative selection in Syk° 3-83^ mice suggested that clonal 
deletion proceeds unimpaired in the absence of Syk (M. Turner and V. Tybulewicz, 
unpublished). Since in vivo Syk is indispensable for full B cell maturation, finding 
unimpaired deletion in Syk° mice was rather unexpected.
Introduction of the 3-83 BCR transgene allows for studies of negative selection, since 
the cognate ligand, MHC class is easily introduced into our chimaeric system. 
Since the 3-83 BCR has higher affinity for than for K ,^ and it does not appear to 
react to K“^, in order to make the assay more sensitive, mice were used as 
recipients since these are expected to show much less negative selection than H2 *^ , or 
H2^^ mice. In addition, the cognate ligand was only expressed on the radioresistant 
elements of the irradiated host animals, thereby decreasing the amount of antigen in 
the system, and also potentially restricting ligand expression to cells that are less 
efficient in causing negative selection. This strategy might allow detection of subtle 
differences in the knockout animals, that would go unnoticed if the deletion was 
rampant.
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4.3.5.3.1 BCR expression
Negative selection can take multiple shapes: deletion of autoreactive cells, receptor 
downmodulation [6 6 ], receptor editing or anergy. In the 3-83 system clonal deletion, 
receptor downmodulation and receptor editing are induced by the presence of the 
negatively selecting ligand [53, 60, 170]. Figure 43 shows that wild type chimaeras 
generated using irradiated recipients show lower IgM^ expression, where IgM^ is 
the IgH allotype of the transgenic BCR. Whether this phenomenon is truly receptor 
downmodulation or/and deletion of high transgene expressors with concomitant 
expansion of low expressors, cannot be distinguished from these data. Importantly, a 
similar level of receptor downmodulation can be seen both in Syk° and Syk°ZAP-70° 
chimaeras in the presence of H2^ on the irradiated host animals. One possible 
explanation for these results is that negative selection uses different signalling 
pathways than positive selection (that is blocked in Syk° mice), and it is also different 
from the ‘wiring’ through the pre-BCR.
Also, as shown in Figure 38, DKO cells remain at the pro-B cell stage even in the 
presence of the BCR transgene. Pro-B cells do not normally express the complete 
BCR, and therefore would not be expected to be physiological targets for negative 
selection. These results are informative, however, since they show that pro-B cells in 
the absence of Syk and ZAP-70 are not inert, some signals can be transmitted from 
the receptors even without these two kinases.
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Plots show Ly-9.1 donor-derived bone marrow cells from chimaeras generated from 
3-83^ fetal livers. Donors are recipients are either or as labelled. 
IglVP identifies cells carrying the BCR transgene.
4.3.5.3.2 CD19 downmodulation
As seen on Figure 43, BCR/IgM'* levels are downmodulated upon cognate ligand 
recognition whether or not Syk and/or ZAP-70 is present in the cells. One difference, 
however, became apparent during analyses of negative selection in these chimaeric 
mice: CD 19 is downmodulated in wild type chimaeras, but less so in Syk° and 
Syk°ZAP-70° mice (Figure 44).
These results show a link between BCR crosslinking and CD 19 downregulation, that 
is not unconceivable, given CD19’s role as a positive regulator of BCR signalling
96
[135]. This phenomenon could be specific for immature cells, where negative 
selection would be expected to take place.
Moreover, the defective CD 19 down-modulation in Syk° or Syk°ZAP-70° mice 
suggests that different signals are needed for BCR and CD 19 down-modulation, 
respectively. Syk/ZAP-70 appears to be needed for the latter, but not the former 
process. Again, the question of maturational stage (immature B cells in wt mice, vs. 
pro-B cells in Syk°ZAP-70° animals) means that we cannot tell if the failure to down- 
modulate CD19 in Syk°ZAP-70° chimeras is due to defective BCR signalling or to an 
intrinsic inability of pro-B cells to downregulate CD 19 following BCR engagement.
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ZAP-70*
B 2 2 0 IgM* CD19
F ig u r e  4 4 .  CD19 d o w n m o d u l a t io n  u p o n  n e g a t iv e  s e l e c t io n  is  p a r t l y  
DEPENDENT ON SYKAND ZAP-70
3-83 transgenic wild type, Syk° and Syk°ZAP-70° chimaeras were generated. 
Recipients were either (no negative selection, solid histograms) or 
(cognate ligand present, leading to negative selection, open histograms) mice, 
(left column) Plots show B220 expression on Ly-9.1 donor-derived bone marrow 
cells.
(middle and right column) Plots show Ly-9.1 B220^ (as gated on left panel, 
horizontal line) donor-derived B lineage cells.
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5 Discussion
One of the major checkpoints in B cell development is the transition from pro-B cells 
to pre-B cells, mediated -  at least partly -  by the pre-BCR. Extensive studies have 
revealed that this signalling step results in differentiation and proliferation, but the 
exact mechanism and signal transduction machinery of this process has not been fully 
explored yet.
Based on experiments conducted using mature B cells and B cell lines, tyrosine 
kinases are prime ‘suspects’ in the early steps of signalling from the pre-BCR. The 
aim of this work has been to further elucidate the role of Syk/ZAP family of tyrosine 
kinases in early B cell development.
Gene targeted Syk mutant animals had been generated [128,159], and analysis of 
these mice showed that in the absence of Syk B cell development is blocked 
incompletely at the pre-BCR step, and completely at the transition from immature to 
mature B cells. The partial block at the pre-BCR suggests that either there are 
different parallel pathways leading from the pre-BCR to the nucleus bringing about 
differentiation, or that other molecule(s) can perform the same functions as Syk, but 
maybe less efficiently. In either case, the complete block at the im m ature^m ature 
transition shows that Syk is non-replaceable at that step.
In order to understand the relationship of Syk to other signalling molecules expected 
to play a role in early B cell development, I took a genetic approach and generated 
different combination mutant mice, missing either Lyn or ZAP-70 tyrosine kinases in 
addition to Syk.
99
5.1 The role of Lyn tyrosine kinase in early B ceil 
development
Lyn was chosen as the most abundant representative of Src-family tyrosine kinases 
(SFK), shown to be associated with the resting BCR and activated with fast kinetics 
after receptor crosslinking [94]. SFKs are thought to contribute to the tyrosine 
phosphorylation of the Iga/p  subunits of the B cell receptor, thereby creating binding 
sites for the tandem SH2 domains of Syk. As a next step Syk becomes tyrosine 
phosphorylated either by autophosphorylation or by transphosphorylation, potentially 
by Lyn. This is, however, not the only role of Lyn in BCR signalling. As other 
positive effects, Lyn can contribute to Btk activation, and thereby influencing Ca"^- 
flux, phosphorylate (and be further activated by) CD 19, thus contributing to PI3K and 
Vav activation. In addition, Lyn can also curtail BCR signalling by activating 
negative regulatory molecules, e.g. CD22-SHP-1 and FCyRIIB-SHIP.
Based on these findings in mature B cells, the combination mutants missing both Syk 
and Lyn could:
-  show the same phenotype as the Syk° mice, suggesting, that at the pre-BCR 
step, the only downstream effector of Lyn is Syk; alternatively, that other 
SFKs can replace Lyn in every aspect;
-  complete block at the pre-BCR step in the double mutant animals would 
suggest that other pathways bypassing the need for Syk are entirely 
dependent on Lyn, or that the other molecule(s) compensating for the absence 
of Syk cannot be called into action without Lyn;
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-  if removing Lyn was to restore differentiation in Syk° animals, one would 
have to postulate a mechanism where the role of Syk is to counteract a 
pathway from Lyn that blocks differentiation, i.e. in the absence of Syk, the 
negative effect of Lyn dominates, that has to be removed to restore 
maturation;
Introduction of a pre-rearranged BCR transgene (3-83) with known specificity (H- 
2^^) allowed testing of negative selection in the absence of Syk [Turner, M. and 
Tybulewicz, V.L.J., unpublished]: deletion of autoreactive B cells proceeds even 
without Syk. In addition, in the HEL-transgenic system [161] in the absence of Syk 
the antigen-binding capacity of B lineage cells in the presence of cognate ligand 
(HEL) is more diminished than in control animals. This result is reminiscent of the 
hyper-responsiveness seen e.g. in the absence of the negative regulatory phosphatase 
SHP-1 [171], suggesting, that Syk may potentially play a negative role in the 
signalling from the BCR.
While Lyn was shown to exert positive as well as negative effect on BCR signalling, 
its negative influence predominates in B cell tolerance: removal of Lyn makes 
developing B cells more sensitive to negative selection [120]. Using the 3-83 system 
in combination with Syk and/or Lyn mutation(s) allows us to assess the relative 
contribution of the two kinases to negative selection.
Homozygous Syk mutant animals die around birth, so in order to assess B cell 
development in the absence of Syk, radiation chimaeras had to be produced from fetal 
livers harvested from wild type embryos or embryos deficient in Syk, Lyn or both. 
Chimeric Lyn° mice showed similar phenotype to the published one [137]: in Lyn°
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mice the proportion of B 2 2 0 ^^  ^mature cells in the bone marrow is dramatically 
reduced, since Lyn appears to be required for successful B cell maturation and/or 
survival in the periphery[172]. In contrast, the generation of immature B cells in the 
bone marrow appears unaffected in the absence of Lyn.
Syk° mice, as demonstrated before, show impaired development into immature B 
cells, and a complete block at the immature mature B cell transition [127, 128]. 
Double ‘knockout’ chimaeric mice show further impairment in B cell development: 
the proportion of bone marrow cells expressing IgM is even lower than in the single 
mutants. This suggests that Lyn, in addition to contributing to Syk activation either 
directly or by phosphorylating Iga/P, thereby enabling Syk binding and activation, 
also has a positive role in early B cell development that is independent of Syk. 
Introduction of an anti-apoptotic transgene (e.g. bcl-2) may help to reveal whether 
promoting survival is the only important role Lyn plays at these early stages.
Further investigation is currently underway to determine the relative contribution of 
Syk and Lyn to the pre-BCR signalling and their role at even earlier steps in B cell 
maturation.
Introduction of the 3-83 pre-rearranged transgene into Syk° animals allows the 
expression of -  transgene-derived -  IgM® on the surface of B lineage cells, proving 
that there is no inherent problem of expressing BCR on the surface. These IgM^ cells, 
however, are still pro-B cells that do not express CD2 (data not shown). This result 
confirms, that Syk° B cell maturation is not blocked because of lack of 
rearrangement, which was expected, since there are some IgM expressing cells in 
Syk° mice even in the absence of the BCR transgene.
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Interestingly, in the bone marrow of Syk° Lyn° mice there are very few IgM® 
expressing cells. Addition of a Bcl-2 transgene, however, appears to correct this 
defect (Figure 13), suggesting that in this BCR transgenic case either Syk or Lyn must 
be present for a survival signal.
Similar analyses in Syk°ZAP-70° mice show only mildly decreased percentages of 
IgM® expressing bone marrow cells in the double knockouts relative to Syk° (Figure 
36). This result taken together with the Syk°Lyn° phenotype suggests that Lyn and 
Syk can transmit signals for survival independently of each other, but at least one of 
these pathways has to be active.
Cell survival defect is only one component in the B cell developmental block seen in 
Syk° and Syk°Lyn° mice, however, since addition of the Bcl-2 transgene -  while 
increases cell numbers -  does not lead to developmental progression, as assessed by 
lack of IgD expression.
Using a BCR transgene of a different allotype (IgM®) from that of the endogenous 
heavy chain (IgM'’) is a convenient tool to assay allelic exlusion at the heavy chain 
locus, and similarly, analysis of endogenous X light chain expression allows the 
evaluation of light chain allelic exclusion in the presence of a K transgene.
3-83"^Syk° mice show minimal endogenous HC/LC recombination; however, 
expression of IgM'’ and X from the endogenous loci is significantly increased in the 
presence of the Bcl-2 transgene (Figure 14, Figure 15). Since Bcl-2 transgene has 
been shown to extend the half-life of IgM^ B cells in this system [159], one 
explanation is that in the absence of Syk allelic exclusion is inefficiently maintained, 
but increased lifespan of cells is needed to accumulate easily detectable numbers of 
cells with two receptors. The fact, that in the absence of both Syk and ZAP-70 heavy
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chain ‘inclusion’ is easily detectable (without a Bcl-2 transgene) (Figure 42) says that 
ZAP-70 can sustain allelic exclusion in the absence of Syk, albeit less efficiently. 
Since the removal of Lyn has not changed endogenous heavy and light chain 
expression in the presence or absence of Syk, Lyn does not appear to be needed for 
allelic exclusion. I have not addressed whether other SFKs can replace Lyn in this 
process.
The 3-83 BCR confers MHC Class I (H-2'" '’) reactivity to transgenic B cells, that 
allows for testing of negative selection by using different MHC backgrounds. The 3- 
83 BCR has low affinity for H-2"’^‘', especially if it is expressed only on the irradiated 
host cells in fetal liver radiation chimaeras. In this system the presence of the cognate 
ligand results in the disappearance of B220'’' cells from the bone marrow, and in the 
enlarged B220'°'^ compartment IgM® expression is about 10-fold lower than in H2‘'‘' 
mice. This phenotype can be brought about by either deletion of all cells expressing 
high levels of IgM®, or by IgM® receptor downmodulation that does not allow for any 
differentiation into a B220'’' compartment, or by the combination of these two 
mechanisms. In addition, the increased proportion of B220^ IgM®  ^cells in the bone 
marrow of H 2 '’‘' chimaeras may be explained by suggesting that the ligand-receptor 
interaction that is not strong enough to cause deletion of IgMa'"’’" cells, induces their 
proliferation instead.
Removal of Lyn leads to somewhat stronger receptor down-modulation (Figure 17), 
which is not unexpected, since Lyn° B cells have been shown to be hypersensitive to 
tolerance induction previously [1 2 0 ].
Syk° mice, however, appear to show unaffected negative selection as assayed by IgM® 
levels in bone marrow cells of H2'’^‘' chimaeric mice. This finding is somewhat 
surprising, given the requirement for Syk at the pre-BCR step and at the immature ->
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mature transition. We do have to keep in mind, however, that although these cells 
express IgM, and therefore look like immature B cells, they may have different 
characteristics from conventional immature B cells due to the impaired development 
in the absence of Syk.
Syk°Lyn° mice show somewhat higher IgM® levels, than Wt, or single mutant animals 
(Figure 17). This could suggest that a small positive contribution of Syk to negative 
selection can be revealed only in the absence of Lyn, because without Lyn, ZAP-70 
may not be competent to replace Syk in this process. However, these effects are only 
marginal; moreover, Syk°ZAP-70° mice can also downregulate IgM® efficiently 
(Figure 43).
In summary, removal of Lyn in addition to Syk resulted in
-  development of immature B cells (in contrast to Syk°ZAP-70° mice);
-  B lineage cells comprising much smaller fraction of the bone marrow both in 
non-transgenic and BCR transgenic animals
-  Bcl-2 transgene correcting the deficit of B lineage cells in the presence of the 
BCR transgene
-  Mildly enhanced effect on allelic exclusion (relative to removal of Syk alone)
-  Similar or mildly smaller receptor downmodulation in the presence of a BCR 
transgene and its cognate ligand.
The conclusion that is emerging from these data -  although further experiments are 
no doubt necessary -  is that the most important role of Lyn in early B cell 
development is in supporting cell survival acting together with and/or in parallel to 
the Syk/ZAP family of tyrosine kinases. In this task Lyn cannot be efficiently
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substituted for by other Src family members. If Src family kinases are important in 
promoting differentiation, Lyn can be substituted for by other family members.
5.2 The role of ZAP-70 tyrosine kinase in B cell development
As discussed in the previous chapter, the incomplete block in B cell development at 
the pre-BCR step seen in Syk° mice became more severe by additional removal of 
Lyn SFK. B cell maturation in these double knockout Syk° Lyn° animals, however, 
is not completely arrested at the pro-B pre-B transition, suggesting that additional 
molecule(s) can replace the function of Syk at this step, albeit inefficiently.
Redundancy among tyrosine kinase family members has been repeatedly seen in 
different aspects of lymphocyte development and function [163]. Since Syk is a 
member of the Syk/ZAP-70 protein tyrosine kinase family that has only two known 
members, Syk and ZAP-70, this prompted an investigation of the role of ZAP-70 in B 
cell development, especially in the absence of Syk. Whereas Syk is known to be 
widely expressed throughout the haemopoietic system (and possibly beyond), ZAP- 
70 has only been detected in T and NK lineage cells and cell lines.
To test whether ZAP-70 contributes in any way to early B cell maturation, mice 
carrying mutant Syk and ZAP-70 alleles, respectively, were intercrossed to generate 
double mutant animals. As in the case of the Syk° single mutants, homozygous 
double knockout (DKO) Syk°ZAP-70° mice also die perinatally, necessitating the
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generation of radiation chimaeras from wild type or different mutant fetal livers as 
donors.
Syk°ZAP-70° DKO mice have been generated before, and newborn animals were 
analysed for thymic T cell development [165]. These studies demonstrated that T cell 
development beyond the DN (CD4'8‘) stage requires at least one of these kinases.
In chimaeric mice I found similar thymic phenotype (Figure 18) confirming that 
radiation chimaeras are useful models for studying lymphocyte development.
5.2.1.1.1 Complete block at the pre-BCR step  in the ab sen ce of Syk and 
ZAP-70
Importantly, analyses of early B cell development in the bone marrow revealed a 
complete absence of IgM^ immature B cells in the DKO animals, in contrast to ZAP- 
70° single mutants, that are indistinguishable from wild type mice, or to the Syk° 
mice, which do contain immature B cells, though in severely reduced numbers 
(Figure 19, Figure 22).
Further dissection of B cell maturational steps in DKO animals using cell surface 
antigen-expression-based staging revealed that in the absence of both of these kinases 
B lineage cells cannot express CD2 (Figure 20), and are thus arrested at the IgM 
CD2 CD43^ pro-B cell stage (Figure 21). In addition, cell size analyses show that all 
these cells remain large (Figure 21), consistent with their pro-B cell stage .
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This phenotype suggests that in the absence of Syk and ZAP-70 pro-B -> pre-B 
differentiation cannot be induced, which is one of the major tasks for the pre-BCR 
signalling pathway.
The reason for this missing signal could be either
-  that ZAP-70 is not required cell-autonomously within the B cell lineage, but is 
must be present in other haemopoietic cell(s);
-  lack of pre-BCR assembly/expression, or
-  failure to transmit a signal from a properly expressed pre-BCR
5.2.1.1.2 The requirement for ZAP-70 (in the ab sen ce of Syk) Is B ceii- 
autonom ous
Given that pre-BCR expression does not appear to be impaired in the Syk°ZAP-70° 
DKO mice, lack of differentiation into the pre-B cell compartment is probably due to 
lack of proper signal transduction from this receptor. Alternatively, since these 
analyses were done on radiation chimaeras, and ZAP-70 was absent in all donor- 
derived fetal liver cells, it is possible, that ZAP-70 is not needed within the B linage 
cells themselves, but rather in other haemopoietic cells that influence B cell 
development in trans, by secreting soluble factors or by expressing surface antigens 
needed for proper interactions with B cell progenitors.
To distinguish between these two possibilities mixed fetal liver radiation chimaeras 
were generated (Figure 25). The aim of these experiments was to allow development 
of Syk°ZAP-70° B lineage progenitors surrounded by other, non-B lineage fetal liver-
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derived cells that are ZAP-70^. As an internal control, the B lineage cells from the 
ZAP-70^ fetal liver can also be analysed. The maturation of these ZAP-70^ B cells 
should not be influenced by the presence of Syk°ZAP-70° haemopoietic cells.
At first, wild type and DKO fetal liver cells were mixed in different ratios and 
injected into irradiated recipients, but the resulting chimaeric mice contained almost 
undetectable numbers of DKG-derived B lineage cells. This is probably caused by 
the lack of proliferative capacity of DKO pro-B cells.
In order to try to match competitiveness between the two donor fetal livers, DKO 
cells were mixed with Syk°(ZAP-70^^^) cells in different ratios. No significant 
competitive difference was seen using these two donor populations. Analysis of bone 
marrow cells from the resulting chimaeras revealed that mixing fetal livers did not 
change the phenotype of the developing B cells, i.e. B cells derived from DKO donors 
in the mixed chimaeras looked identical to those in unmixed chimaeras generated 
from DKO livers (Figure 26, Figure 27) This result demonstrates that the effect of 
ZAP-70 removal is cell-autonomous, i.e. ZAP-70 must be present within the B 
lineage cells themselves to allow some developmental progression in the absence of 
Syk across the pre-BCR checkpoint. Whether ZAP-70 exerts this function at the pre- 
BCR step, or it is needed at earlier developmental stages cannot be concluded from 
these experiments.
Syk and ZAP-70, though homologous in domain structure and primary sequence, 
have distinct expression pattern in the haemopoietic system and beyond. While Syk 
is found in T, B, NK cells, macrophages, dendritic cells, platelets, eosinophils, 
vascular endothelium, mammary gland tissue, etc., ZAP-70 protein has only been 
detected in T and NK lineage cells. Results discussed above from mixed chimaera
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experiments suggest that ZAP-70 must be expressed within the B lineage cells 
themselves.
To address this issue at single cell level, I attempted to analyse ZAP-70 protein 
expression by intracellular flow cytometry. I used different monoclonal and 
polyclonal antibodies with different permeabilization and fixing protocols but could 
not detect any reproducible difference between wild type and ZAP-70° thymocytes.
Short of intracellular staining I resorted to Western blot analysis on populations of 
cells. Since, ZAP-70 is expressed in T and NK lineage cells, it was necessary to use 
sorted cells of well-defined cell surface phenotype. If ZAP-70 is expressed in B cells, 
it may not be present, or present at the same levels throughout maturation. The 
developmental studies of the DKO animals demonstrated that ZAP-70 plays a role at 
the pro-B->pre-B transition, therefore pro-B cells and pre-B cells appeared obvious 
candidates for B lineage cells expressing ZAP-70. Also, in the T lineage, Syk 
expression is downregulated upon pre-TCR signalling [168], therefore if ZAP-70 
were to play somewhat analogous role in B cells to that of Syk in T cells, ZAP-70 
expression may be higher at earlier stages. Pure, uncontaminated pro-B cell 
population can be obtained from RAG-1° bone marrow, since in the absence of 
recombination, these cells cannot progress into the pre-B cell compartment. 
Progression to the pre-B stage can be achieved, however, by the introduction of a 
heavy chain only transgene into RAG° mice, which allows pre-BCR signalling, but in 
the absence of any endogenous light chain rearrangement no further differentiation is 
possible. For comparison splenic CD 19  ^B cells were also included. This latter 
population is heterogenous, containing a mixture of transitional, mature and marginal 
zone B cells.
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Western blot analysis of different sorted B cell populations demonstrated that ZAP-70 
is indeed expressed in the B lineage. Comparison with expression levels found in 
total thymocytes revealed that while pro-B and pre-B cells have somewhat less ZAP- 
70 expression than thymocytes, splenic B cells express comparable amounts. This 
was surprising, since previously ZAP-70 was not detected in peripheral B cells [156].
5.2.1.1.3 Pre-BCR can be assem bled  and exp ressed  in DKO B cells
The pre-BCR is composed of a jLt heavy chain (HC) complexed with the so-called 
surrogate light chain (SLC), which in turn contains two proteins, Vpre-B and 15.
Only a very small portion of all produced /x heavy chain actually gets to the surface as 
pre-BCR, most of the /x protein stays in the cytoplasm, where it is easily detectable by 
intracellular flow cytometry. Analysis of intracellular heavy chain expression proves 
that fi heavy chain can be produced in the absence of Syk and ZAP-70, that is 
detectable in chimaeric bone marrow pro-B cells as well as in fetal liver B lineage 
cells (Figure 23 and data not shown). Importantly, the portion of cells expressing 
heavy chain in the cytoplasm is much lower in the DKO mice, than in Wt, ZAP-70° 
or even Syk° animals, consistent with the hypothesis that the expansion of pre-B cells 
following pre-BCR signalling, which is yet another role for this receptor, is blocked.
Detection of heavy chain protein in the cytoplasm proves that there is at least some 
level of heavy chain rearrangement ‘allowed’ in the absence of Syk and ZAP-70.
This in turn suggests, that if there is a pro-BCR signal needed to allow/initiate HC
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recombination, as implied by the phenotype of Igb° mice [10] (see Introduction), this 
does not require either of the Syk-family tyrosine kinases.
Rearrangement at the HC locus was also assessed using a PCR assay. Rearranged 
alleles were detected in fetal liver DNA samples from all four genotypes (Wt, ZAP- 
70°, Syk° and Syk°ZAP-70°) using upstream primers specific for a very frequently 
used 5’ VH family, VHJ558 and downstream primers binding to sequences 3’ of JH4 
(Figure 41). These data confirm that heavy chain rearrangement can be initiated and 
completed in the absence of any Syk/ZAP family protein kinases. The detection of 
recombinations using the VHJ558 family of V-region gene segments was important, 
since a signal appears to be required for progression from 3’ VH segments to more D- 
distal 5’ VH families as shown by the phenotype of the IL-7Ra° animals. These 
mice can rearrange D-proximal, but not D-distal VH genes (such as VHJ558) [12]. 
The Syk°ZAP-70° recombination results therefore show that Syk/ZAP-70 are not 
required for the pathway that leads from IL-7Ra and influences locus accessibility 
and/or the recombination machinery.
In addition to heavy chain rearrangement and cytoplasmic expression, surrogate light 
chain expression on the surface of pro-B cells was also detectable without Syk and/or 
ZAP-70 (Figure 24), suggesting that a pre-BCR can indeed be formed on Syk°ZAP- 
70° B lineage cells, and it is the function of this receptor that is impaired without 
these two kinases.
112
5.2.1.1.4 ZAP-70 can function in B iineage ceiis
Results discussed in the previous chapter provide evidence that ZAP-70 is present in 
B lineage cells, but can it also function in these cells? To answer this question, I 
made use of a recently described system, showing that RAG° pro-B cells can be 
induced to differentiate by administering anti-IgP antibody intraperitoneally to 
crosslink IgP in vivo [122]. If both Syk and ZAP-70 function downstream of IgP, as 
was shown for Syk in mature B cells, then Syk° ZAP-70° DKO pro-B cells should not 
be able to mature further upon anti-IgP injection. This is indeed the result we 
obtained: RAG° pro-B cells show surface phenotype changes consistent with 
differentiation into pre-B cells, whereas DKO pro-B cell are not influenced by the 
injections. RAG° pro-B cells cannot express any pre-BCR on their surface, since 
they cannot rearrange the heavy chain, therefore the effect of IgP crosslinking is 
understood to be due to the stimulation of the so-called pro-BCR, composed of -  
among others -  Iga/p  and calnexin. This signalling is assumed to model a pre-BCR 
signal, since the phenotypic changes are similar to those found at the pro-B^pre-B  
transition. Whether a ‘real’ pre-BCR reacts similarly to IgP crosslinking has not been 
possible to test yet, since as soon as a pre-BCR assembles on the surface it appears to 
induce differentiation of pro-B cells into pre-B cells. Anti-IgP injection into the 
Syk°ZAP-70° chimeras is likely to have cross-linked both a pro-BCR and pre-BCR 
on the surface of the Syk°ZAP-70° pro-B cells.
Instead of comparing pro-BCR signalling on RAG° B cells with pro-BCR+pre-BCR 
signalling on Syk°ZAP-70° DKO cells a more appropriate experiment would be a 
three-way comparison between RAG°, SYK°RAG° and Syk°ZAP-70°RAG° mice, 
testing the pro-BCR in all three cases and directly assessing the relative contributions
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to signalling by Syk and/or ZAP-70. The mice needed to perform this experiment are 
currently being generated.
A possible test for pre-BCR (instead of pro-BCR) signalling using the IgP 
crosslinking could be to introduce an inducible Syk transgene into Syk°ZAP-70° pro- 
B cells and induce Syk expression in vitro before anti-IgP treatment, then assay 
biochemical events.
5.2.1.1.5 The 3-83 BCR transgene
Use of a BCR transgene makes the analysis of a cohort of developing B cells with the 
same specificity possible, and in the case of the 3-83 transgene that was used during 
these studies the cognate ligand is also known (MHC Class I, H2k,b), which can 
easily be introduced into the system.
The questions I wanted to answer using this transgene were:
-  does a pre-rearranged BCR transgene relieve the developmental block seen in 
Syk° and Syk°ZAP-70° DKO mice? If it does, then either the rearrangement 
process is impaired or -  since this HC+LC transgene comes onto the surface 
earlier than a normal BCR -  a BCR can use different pathways for inducing 
differentiation than a pre-BCR;
-  is Syk and/or ZAP-70 involved in allelic exclusion at the heavy and/or light 
chain locus? The process of allelic exclusion can be conveniently analysed in the 
presence of a transgenic BCR, since transgenic and endogenous heavy chains can 
be distinguished by choosing different allotypes for the two, and the transgene
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codes for K light chain, therefore any X light chain has to be coded for by 
endogenous genes.
is Syk and/or ZAP-70 needed for negative selection of autoreactive B cells? 
The presence of the cognate ligand converts B cells expressing the transgene- 
encoded BCR into autoreactive cells, the fate of which can be studied in the 
presence or absence of Syk/ZAP-70.
5.2.1.1.6 Transgenic BCR cannot relieve the maturationai block in DKO 
B ceiis
As discussed above, Syk°ZAP-70° DKO B cell development is arrested at the pro-B 
cell stage. Introduction of the 3-83 BCR transgene resulted in surface expression of 
transgene-encoded IgMa in the bone marrow of DKO cells, giving these cells the 
appearance of immature B cells. Futher phenotypic analysis, however, established, 
that -  despite BCR expression -  these 3-83^ Syk°ZAP-70° DKO B cells are still pro- 
B cells.
Rearrangement analysis of DKO B cells -  in the absence of the transgene -  appeared 
comparable to wild type cells (see above), which already suggested that 
recombination defect is probably not the cause of the developmental block. The lack 
of maturational progress upon transgenic BCR expression confirms this, and in 
addition suggests that even if a HC + conventional LC is used instead of a pre-BCR, 
which is known to allow progression from pro-B cells to pre-B cells in e.g. RAG°
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mice, signalling from this receptor still needs Syk and/or ZAP-70 to induce 
differentiation.
Moreover, detection of the transgenic BCR on the surface also demonstrates that there 
is no inherent problem in DKO B cells with synthesis of immunoglobulin and its 
transport to the cell surface.
5.2.1.1.7 Impaired allelic exclusion  in DKO B ceiis
Allelic exclusion at the heavy chain locus is understood to be one of the consequences 
of pre-BCR signalling. Since a functional pre-BCR requires [i HC protein synthesis 
and complex formation with the surrogate light chain, a signal through this receptor 
means that the heavy chain has passed ‘quality control’. A logical step, therefore is to 
stop any further rearrangement at the heavy chain locus of the other allele, known as 
allelic exclusion.
One way of testing this process is to use mice heterozygous at the heavy chain locus, 
carrying two different allotypes at the two different alleles, then assess the fraction of 
cells expressing /x protein from both alleles. These mice are currently being 
generated.
Alternatively, introduction of a pre-rearranged transgene has been shown to induce 
allelic exclusion, resulting in no endogenous VH-DJH rearrangement, and as a 
consequence no endogenous fi HC allotype expression. Introduction of the 3-83 
transgene allowed this type of analysis. As seen in the phenotypic studies, this
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transgene can be expressed already in pro-B cells, it is expressed probably as early in 
ontogeny as the pre-BCR would be.
Allelic exclusion at rearrangement level was assessed similarly to the assay used for 
nontransgenic samples. PCR analysis of VH-DJH recombinations using VHJ558 and 
3’ of JH4 primers revealed that the 3-83 transgene is indeed very effective in 
preventing any endogenous rearrangement in wild type and ZAP-70° mice. In 
contrast, the Syk mutation already impairs allelic exclusion and the presence of 
endogenous rearrangement is even more marked in the DKO fetal liver cells. These 
results show that a signal from the pre-BCR (which in this case is replaced by a BCR 
expressed on pro-B cells) that shuts down endogenous rearrangement requires Syk or 
ZAP-70, and that ZAP-70 is less effective in mediating this effect than Syk.
Analyses at the protein level showed that a significant fraction of DKO B cells can 
express endogenous heavy chain on the surface in addition to the transgenic BCR. 
This result further confirms that there is endogenous rearrangement in these mice 
carrying the transgene. Since we cannot detect [i expression on DKO pro-B cells in 
the absence of the transgene (as a pre-BCR), this result also suggest that endogenous 
[i heavy chain probably pairs with transgenic light chains, that allows high levels of 
surface expression.
Light chain allelic exclusion is rather difficult to assay in these mice. The transgene 
encodes a k  light chain, and in the absence of allotype-specific antibodies, surface 
expression of endogenous K chains cannot be determined. A, light chain expression 
was not detected even in the absence of the transgenic BCR on DKO B cells. The 
reason for this could be that DKO pro-B cells cannot reach the stage (pre-B cells) 
when X rearrangement would be initiated. In contrast, by PCR, K rearrangement can
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be detected in the absence of the transgene, but K is known to start recombination 
before X, and a small fraction of k  rearrangement can even start before any HC 
recombination is complete. Alternatively, Syk and or ZAP-70 is directly involved in 
initiating/allowing X light chain rearrangement, as it was also suggested for Btk [132].
5.2.1.1.8 Negative selection  can proceed without Syk and ZAP-70
Introduction of the cognate ligand (H-2K’’) for the 3-83 transgene allows the analysis 
of negative selection with or without Syk and ZAP-70. Restricting this low affinity 
ligand to the radio-resistant elements of the host in fetal liver radiation chimaeras 
induces negative selection as detected by a lack of idiotype^ cells in the periphery and 
IgM® downmodulation in the bone marrow.
In the absence of Syk and both Syk and ZAP-70 the same effect of the ligand can be 
seen as in wild type mice: only IgMa'®'  ^bone marrow B cells can be detected. Thus 
IgMa^^'’ B cells are being eliminated even in the absence of Syk and ZAP-70. 
However, CD 19 down-modulation in response to H-2K'’ seen in Wt mice was absent 
in Syk°ZAP-70° animals. These results suggest that at least some signal transduction 
pathways can proceed in the absence of both Syk and ZAP-70. This is in contrast to 
the complete block seen in pre-BCR signalling in Syk°ZAP-70° pro-B cells as read 
out by failure of differentiation to the pre-B cell stage, proliferative expansion and 
allelic exclusion.
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In the case of negative selection an external ligand is implicated, whereas an external 
ligand may not be necessary for pre-BCR signalling. This ligand difference may 
translate into completely different signal propagation machinery.
Alternatively, if receptor downmodulation is due to internalisation, this process may 
be independent of Syk and ZAP-70.
The disadvantage of using the 3-83 model to study negative selection in DKO mice is 
that B cell development in these mice is blocked at the pro-B cell stage, a 
compartment in which negative selection does not usually occur. One approach to 
overcome this would be to generated a mouse strain with a conditional Syk gene, 
allowing Syk to be turned off in immature B cells, the normal target of negative 
selection
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6 Conclusion
The work presented here tried to explore the relative role of Syk/Lyn and Syk/ZAP-
70 kinases, respectively in early B cell development.
From the results discussed the following conclusions can be drawn:
-  as published before, in the absence of Syk there is an incomplete block at the 
pre-BCR step, and a complete block at the immature —> mature transition 
stage of B cell maturation
-  the incomplete block at the pro-B —> pre-B cell transition becomes complete 
by the additional removal of ZAP-70
-  ZAP-70 is present within B lineage cells and is required for B cell 
development in the absence of Syk
-  ZAP-70 can function in B lineage cells, and can -  albeit inefficiently -  replace 
Syk
-  Signalling through the pre-BCR absolutely requires Syk or ZAP-70 for (at 
least) changes in surface protein expression, expansion and allelic exclusion
-  Even though the immature —> mature B cell transition absolutely requires Syk, 
and at this stage Syk cannot be replaced by ZAP-70, not all aspects of the 
BCR signalling are impaired in Syk°ZAP-70° mice
-  Removal of Lyn -  in addition to Syk -  revealed that in early B cell 
development Lyn plays an important role in supporting cell survival, whereas
120
other Src family member kinases can possibly susbstitute for Lyn in 
differentiation.
Future work will address the role of Syk and Zap-70 at later stages of development, 
by generating inducible/conditional Syk mutant or transgenic models.
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7 Materials and Methods
7.1 Solutions and Media
TE
ACK lysis buffer
Tail lysis buffer
FACS buffer 
for Southern blotting: 
50xT A E  
20 X SSC
Denaturing solution 
Pre/Hybridization Solution
t
for Western blotting:
4 X Lower Tris Buffer 
4 X Upper Tris Buffer 
10 X Running Buffer 
2xRSB
10% polyacrylamide gel
Stacking gel
CAPS-buffer 
Stripping buffer
Blot-wash
10 mM.Tris.Cl, pH 7.4,1 mM EDTA, pH 8.0 
0.15 M NH4C1 -h 1.0 mM KHC03 + 0.1 mM Na^EDTA 
pH7.2-7.4
0.1 M Tris.Cl pH 8.5 + 5 mM EDTA + 0.2% SDS + 0.2 
M NaCl
PBS + 0.1% Na-azide + 0.5% BSA
40 mM Tris-acetate + 2 mM Na2EDTA.2H20 
3 M NaCl + 0.3 M Na3citrate.2H20 (pH 7.0)
0.5 M N a O H + 1.5 M NaCl
0.2 M NaP04 + 1 mM EDTA + 1 % BSA + 7%  SDS + 
15% formamide
1.5 M Tris-Cl + 0.4% SDS pH 8 . 8  
0.5 M Tris-Cl + 0.4% SDS pH 6 . 8
3.03% Tris-Cl + 1 % SDS + 14.42% Glycine pH 8.3 
20% glycerol + 6 % SDS + Ix upper Tris buffer + 
0.005% bromophenol blue 
10% Acrylamid/Bis-Acrylamide + Ix Lower Tris 
Buffer+0.033 % ammonium-persulfate +
0.066% TEMED 
3.75% Acrylamide/Bis-acrylamide + Ix Upper Tris 
Buffer + 0.05% ammonium-persulfate + 0.1% TEMED 
2.21% CAPS in H 20, pH 11.0
62.5 mM Tris.Cl pH 6.7 + 100 mM 2-mercaptoethanol
+ 2% SDS 
0.05% Tween-20 in PBS
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7.2 Mice
Transgenic and gene targeted mutant mice were bred and maintained in the animal 
facilities of the National Institute for Medical Research according to Home Office 
regulations, ^y^j-mutant mice (Sy^ tmi^ yb/tmiiyb^  were generated in our laboratory [127], 
3-83 transgenic mice were provided by David Nemazee [59], Bcl-2 transgenic mice 
by Andreas Strasser [162], Ly«-mutant mice by Ashley Dunn [137], Rag-1 knockout 
mice by D. Baltimore [7], Zap-70-mutant mice by Art Weiss [167], HC-186 and EfiX 
transgenic mice by Fred Alt [169]. 129/Sv, B10.D2/o, BALB/c, C57BL/10, (BALB/c 
X B10.D2)F1 and (BALB/c x C57BL/10)F1 mice were provided by the SPF (specific 
pathogen free) facility of the Institute.
7.3 Antibodies and Cell Lines:
The following antibodies were purchased for use for flow cytometry or Western 
blotting:
COMPANY ANTIBODY CLONE/CAT.NO.
B ecton-Dickinson B220-CyChr RA3.6B2
Becton-Dickinson BP-l-PE 6C3
Becton-Dickinson CD 19-biotin 1D3
Becton-Dickinson CD2 (LFA-2)-PE RM2-5
Becton-Dickinson CD24 (HSA)-PE M l/69
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Becton-Dickinson
B ecton-Dickinson
B ecton-Dickinson
Becton-Dickinson
Becton-Dickinson
B ecton-Dickinson
Becton-Dickinson
B ecton-Dickinson
B ecton-Dickinson
B ecton-Dickinson
B ecton-Dickinson
Becton-Dickinson
B ecton-Dickinson
Becton-Dickinson
Caltag
Caltag
Caltag
Caltag
Santa Cmz
Santa Cmz
Santa Cmz
DAKO
Cell Signalling Techn. 
Life Technologies
CD25-PE
CD43(leukosialin)-biotin
CD4-PE
Igp-purified
IgD-FITC
IgMa-FITC
IgM-FITC
IL-7Ra-PE
kappa-PE
lambdai.2-biotin
Ly-9.1-biotin
Ly-9.1-FITC
Streptavidin-PE
ZAP-70
B220-APC
CD19-Tricolor
CD 8 a-APC
Streptavidin-PECy7
ERK-1
ZAP-70
phospho-ERK
rabbit-anti-mouse-Ig-HRP
ZAP-70
Streptavidin-Red613
PC61
S7
H129.19
HM79b
ll-26c.2a
IgH 6 ®
R6-60.2
SB/14
02155A
R26-46
30C7
30C7
Z24820
RA3-6B2
RM7706
RM2205
SA1012
K23
LR
E4
PO260
rabbit polyclonal Ig
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7.3.2 Labelling of antibodies
7.3.2.1 FITC (fluoresceins^ isothiocyanate)
Protein G-purified 54.1 mAb at 1 mg/ml concentration was dialysed against 0.25 M 
carbonate buffer (pH 9.3) for at least 1-2 hours. FITC (Molecular Probes, Oregon) 
was dissolved in DMSG to yield 10 mg/ml stock concentration, then 100 [xg FITC 
was added to each mg protein, and rotated overnight at 4°C. Conjugated antibody 
was dialysed against PBS, then stored at -20°C or at 4°C in 0.1% Sodium azide.
7.5.2.2 Biotin
Protein G (Hi-Trap, Pharmacia) purified HM79b mAb was conjugated to biotin using 
BZ-Link Sulfo-NHS-LC-biotinylation kit (Pierce, Rockford, IL). 0.2 mg sulfo-NHS- 
LC-biotin was added to 2 mg protein in 1 ml PBS, and incubated for 2 hours on ice. 
Using the column provided by the kit, conjugated protein was desalted then 
concentration determined by spectrophotometer. Conjugated antibody is stored at 
4°C in 0.1% sodium azide.
7.3.2.S APC
APC-conjugation of anti-mouse CD 19 (1D3) was performed using the Phycolink 
APC labelling kit (ProZyme) according to manufacturer’s protocol. APC-conjugated 
antibody was then stored at 4°C in 0.1% sodium azide protected from light.
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Serotec Goat-anti-mouse-IgM-FITC STAR8 6 F
Amersham-Pharmacia Protein-A-HRP NA 9120
24G2 (Fc-block) hybridoma was a gift from B. Stockinger, 54.1 (anti-clonotype for 3- 
83 transgenic BCR) from D. Nemazee, 1.19 (anti-IgD) and B76 (anti-mouse fi) from 
G. Klaus, HM-79b (anti-Igp) from T. Nakamura [11], biotinylated LM-34 (anti-X5) 
and VP-245 (anti-VpreB) from L. Martensson (with permission from H. 
Karasuyama), TAT-1 (anti-tubulin) from S. Ley, K^-biotin (MV3) from R. 
Zamoyska.
7.3.1 Purification of antibodies
Hybridoma supernatants were cleared of debris by centrifugation at 10,000 rpm in 
Beckman JA-25 centrifuge for 10 min, and the pellet discarded. Protein-G column 
(connected to Pharmacia LKB fraction collector) was pre-washed with PBS-Azide, 
then supernatant added. Unbound material washed off with excess amount of PBS, 
then specifically bound protein eluted with 0.2M acetic acid. Eluted fractions were 
neutralized with IM  Tris.HCl (pH 11), protein concentration determined by 
spectrophotometer. Peak fractions were pooled, then dialysed overnight against PBS. 
If needed, CentriconlO (Amicon) concentrators were used to increase protein 
concentration.
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7A  FACS analysis and FACSortIng
Bone marrow cells were obtained by flushing out cells from the femur and tibia of 
both hind legs. Spleens were pressed through a 75 /xm nylon mesh (John Stanier) to 
obtain a cell suspension. Red blood cells and dead cells were removed by spinning the 
cell suspension through an equal volume of Lympholyte (Cedarlane laboatories), then 
collecting live lymphocytes from the interface. Live cells were counted in trypan 
blue solution. 10  ^cells were stained in 50/d FACS-buffer, containing the appropriate, 
pre-titered antibodies. To avoid non-specific binding of antibodies through Fc 
receptors, cells were pretreated with 24G2 (anti-FcR) antibody, before adding specific 
antibodies. Three-colour analysis was done on FacScan, four colour analysis on 
FacVantage and FacsCalibur, sorting on FacStar Plus and MoFlo(Cytomation) using 
Cellquest software (all Bee ton Dickinson, Mountain View, CA). Plots shown 
represent at least three independent experiments.
7.4.1 Intracellular staining
Surface staining of samples was carried out as described above. After two washes in 
PBS, cells were fixed in 3% paraformaldehyde on ice for 1 hour to overnight.
Samples were washed twice in PBS, then autofluorescence from paraformaldehyde 
was quenched by incubation in 50 mM NH 4CI. After another wash in PBS, cells were 
permeabilised using 1% NP-40 (in PBS) for 3 min, followed by a PBS wash, staining 
with the intracellular antibody and a final PBS wash.
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7.5 Genotyping of Mice
7.5.1 FACS analysis
FACS analysis for genotyping purposes was done using peripheral blood collected 
with heparinized capillaries. 35 /xl FACS-buffer containing the appropriate 
antibodies was added to 15/xl blood, incubated for 20 minutes on ice, then 1 ml ACK 
lysis buffer was added to lyse the red blood cells. After 2 minutes (hemolysis visible) 
cells were washed with FACS buffer before analysis on FACScan.
7.5.2 Southern Blot
2-5 mm tail-snips were taken from mice between 16-21 days of age using local 
anaesthetics. Tails were incubated overnight in 500 pii tail-lysis buffer containing 0.1 
mg/ml Proteinase K (Boehringer Mannheim) in a shaking waterbath at 55°C. Next 
day tubes were spun down for 2 0  min at 13,000 rpm and supernatant transferred to 
fresh tubes. 350 /xl isopropanol was added and mixed well. DNA becomes visible as 
a white precipitate. Tubes were spun down for 15 min at 13,000 rpm, supernatant 
removed, pellet washed once with 70% ethanol. Supernatant was removed as 
completely, as possible, then pellet was allowed to air-dry. 100/xl TE was added to the 
DNA and placed in a 37°C incubator for a few hours to facilitate resuspension. 15 /xl 
of this DNA solution was cut with the appropriate restriction enzymes in a 40/xl 
reaction, and incubated at 37°C overnight. Digests were separated on a 0.8% agarose
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gel at low speed overnight. Gels were then denatured in Denaturing solution, and 
DNA transferred onto Hybond N"*" nylon membrane (Amersham) via capillary transfer 
in 20xSSC. DNA was fixed on the membrane with 0.4M NaOH. Probes were 
labelled with ^^P-dCTP using Random Primed Oligonucleotide Labelling Kit 
(Boehringer Mannheim), then purified on NICK columns (Pharmacia). Hybridization 
was carried out at 65°C for 16 hours. Blots were washed in 2xSSC/0.5%SDS for 
2x20 min, then in 0.1xSSC/0.5%SDS for 2x20 min. Blots were then placed into 
autoradiograph cassettes with Kodak Xomat AR films. Films were developed 2-7 
days later. Alternatively, blots were placed into phosphoimager cassettes and scanned 
1-3 days later on Storm 860 phosphoimager (Dynatech).
7.5.3 Earpunch-PCR
DNA was prepared from earpunches by adding 58.5 fil dH20,10/xl lOx PCR buffer II 
(without MgCl2), 1 /xl 10 mg/ml Proteinase K, 0.5 /xl Tween-20 and 20 /xl Chelex 
(Bio-Rad Instagene DNA Matrix) to each sample. After 30 min incubation at 55°C, 
10/xl 25mM MgCl2 is added to each sample, then incubated for a further 2 hours at 
55°C. In order to inactivate Proteinase K, samples are incubated for 15 min at 95°C, 
then spun down at 13,000 rpm for 10 sec. 10/d of the supernatant is used for 50 /d 
PCR reactions. The 40/xl PCR reaction mix contains 4 /xl lOxPCR buffer II (without 
MgClz), titered amounts of 25mM MgCl2 , 0.8 /xl 25mM dNTP mix, 1/xl (12.5 pmol) 
of each primer, 0.2 /xl Taq polymerase (Perkin-Ellmer) and water. PCR reactions are 
run on PE-6700 PCR machine with annealing temperatures and cycle numbers 
optimised for each primer set.
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7.5.4 Primer sets used for genotyping by PCR
Syk A AGAGAAGCCCTGGCCATGGAC
B GTCCAGGTAGACGTGTTTGGGC
G GAGAGTAGTGAGAGGTGGT
Lyn A TGGTAGTTGGATTTGTGAGGTGG
B GAGGTGGAGGATAGGTGGGTGTTT
G AGAGAGGTAGAGGGTTGTTTGGTG
RAG-1 A GAGGAGGTGGAAGGATGTATTGTG
B TTGGAGAGTGAGTTGGTGATTGGA
G AGGGGTGATATTGGTGAAGAGGTT
3 - 8 3  A GAGGTTGGTGGTAATGAGTGGG
B TGGTGGGGGGTGGGAAGGTG
Bcl-2 A TTGGAGAAGGGGATGGGAGGGT
B AGTTGGGGGAGATGTGGAGG
ZAP-70 A GGAGATATGGAGTGTGGGTGGTGTA
B TGG GTA GGG GTG ATA TTG GTG AAG A 
G GGG TGG GTG TAG GGA GTG TGG TAG A 
H C -186 A GGGGAATTGTGGTGGAAGGGTTGTGGG
B GGGGTAGGGAGAGTGTGAGAGTGGTGG
7.5 Generation of Radiation Chimaeras
Recipient mice are treated with 0.1 M HCl in their drinking water for 1 week prior to 
irradiation. On the day of the transfer, recipient mice receive 2x5 Gy total body 
irradiation, administered 3 hours apart to minimise GI tract damage. Donor fetal 
livers are washed in serum-free media three-times, and filtered through a 75/xm nylon 
mesh before injecting on average 5 million cells (as determined by Casyton Cell 
Counter, Scharfe Systems, Reutlingen) in 0.2 ml volume iv. (tail-vein) into the 
irradiated recipients at any time up to 24 hours following the second irradiation. Mice
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are treated with 0.16% Neomycin-sulfate (Sigma) in their drinking water for 4 weeks 
post-transfer. Mice are analyzed between 8-14 weeks after transfer.
7.7 Freezing Fetal Livers
Timed matings are set up, and vaginal plugs checked every morning. The day the 
plug is found is considered day 0.5. Embryos are sacrificed at dayl6.5 of gestation, 
fetal liver removed, made into cell suspension in RPMI media, using 75/xm nylon 
mesh or 70/xm cell strainers (Falcon), spun down for 5 min at 1,400 rpm. Supernatant 
is removed, cell pellet is then resuspended in 900 /xl FCS and transferred into freezing 
vials. 100/xl DMSO is added, mixed, then frozen in -70°C freezer.
For genotyping purposes, part of the embryonic brain is removed and DNA prepared.
7.8 Western Blotting
Cytoplasmic lysates are prepared by lysing cells in IxCell lysis buffer (NEB) 
containing small peptide inhibitors (Sigma) and 1 mM Na^VO^. Lysis is allowed to 
proceed for at least 30 min on ice, which is followed by centrifugation for 30 min. at 
13,000 rpm at 4°C to remove nuclei and debris. Supernatant is transferred into fresh 
tubes, and equal amount of 2xRSB (reducing sample buffer) is added, mixed well, 
then denatured for 5 min at 100°C.
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Samples are loaded onto a 10% polyacrylamide gel, then transferred onto PVDF 
membrane by electroblotting in CAPS solution. Blots are blocked in 15% dry milk in 
PBS/Tween for at least four hours, then washed, incubated with the primary antibody 
(in PBS/Az/milk) for 1 hour, washed extensively, incubated with the secondary 
antibody for 1 hour and washed again. Signal is revealed by ECL (Amersham) using 
Kodak XB200 or X-OMAT UV film. Before reprobing, blots are stripped for 25 min 
at 50°C, washed extensively and blocked again.
7.9 Rearrangement analysis -  Bulk fetai liver PCR
Day 16.5 fetal livers were harvested, red blood cells removed by differential lysis 
using ACK lysis buffer. Cell concentration was determined using Casyton cell 
counter. 10 million fetal liver cells were pelleted, then resuspended in 500 /xl tail 
lysis buffer containing 200/xg.ml Proteinase K (Boehringer Mannheim). Digestion 
was carried out for at least 2 hours but not more than 24 hours at 55°C. 350/xl 
isopropanol was added to precipitated the DNA. DNA was collected as a pellet after 
centrifugation at 13,000 rpm for 20 min. Pellet was washed once with 70% ethanol, 
then air-dried, resuspended in 500 /xl TE and left overnight at 37°C to allow for 
complete resuspension. DNA content was determined by spectrophotometer (OD260) 
and sample volumes were adjusted to yield equal DNA concentration for each 
sample.
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First round PCR reactions were set up using 1 /xl of 1:1, 1:5, 1:25 and 1:125 dilutions 
of the stock DNA samples, that corresponds to 20,000 - 4,000 -  800 -  160 cells. For 
the second round reaction 1 /xl of the first round PCR product was used.
The 50 /xl reaction mix for both rounds contained IxPCR buffer, 3 mM MgClz, 0.4 
mM of each of the four dNTPs, 12.5 pmol primers and lU  Taq polymerase (AB 
Systems).
Primers used [12,48]:
VHJ558-1 ACCATGGGATGGAGCTGKATCWTBC
VHJ558-2 GTGARGCCTGGGRCTTCAGTGAAG
DHFLSP-1 ACAAGCTTCAAAGCACAATGCCTGGCT
DHFLSP-2 ACGTCGACTTTTGTSAAGGGATCTACTACTGT 
JH4-1 AGGCTCTGAGATCCCTAGACAG
JH4-2 GGGTCTAGACTCTCAGCCGGCTCCCTCAGGG
PCR reactions: 
First round: Second round:
94°C 3’ 
94°C 45’ 1
65°C 45”  ^2x
72°C 1’45” J 
94°C 40” 1
63°C 45” (■ 3x
72°C 1’45” J 
94°C 40” 1
60°C 45” 1-20X
72°C 1’45” J 
I T C  T  
24°C ~
94°C 3’
94°C 40” 1
67°C 45”  ^3x
72°C 1’45” J
94°C 40” 1
64°C 45” 1-27X
72°C 1’45” J
72°C 7’
24°C O O
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30 jLtl of PCR products were separated on 2% agarose gels in Ix TAE, then transferred 
onto Hybond N+ (Amersham-Pharmacia) membranes as for Southern blots (see 
above). The probe for hybridization contains a JH3-JH4 fragment (a kind gift from 
K. Rajewsky).
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